Multiple testing using the posterior probability of half-space: application to gene expression data. by Labbe, Aurelie
Multiple testing using the posterior probability of




presented to the University of Waterloo
in fulfilment of the




Waterloo, Ontario, Canada, 2005
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Abstract
We consider the problem of testing the equality of two sample means, when the number
of tests performed is large. Applying this problem to the context of gene expression data,
our goal is to detect a set of genes differentially expressed under two treatments or two
biological conditions. A null hypothesis of no difference in the gene expression under the
two conditions is constructed. Since such a hypothesis is tested for each gene, it follows
that thousands of tests are performed simultaneously, and multiple testing issues then
arise. The aim of our research is to make a connection between Bayesian analysis and fre-
quentist theory in the context of multiple comparisons by deriving some properties shared
by both p-values and posterior probabilities. The ultimate goal of this work is to use the
posterior probability of the one-sided alternative hypothesis (or equivalently, posterior
probability of the half-space) in the same spirit as a p-value. We show for instance that
such a Bayesian probability can be used as an input in some standard multiple testing
procedures controlling for the False Discovery rate.
The first chapter of this thesis presents an introduction to the problem of cDNA mi-
croarray data. The underlying biological principles of this type of data, as well as the
associated statistical issues are discussed. In the second chapter, we follow the work of
Dudley & Haughton (2002) regarding the asymptotic normality of posterior probabilities
of half-spaces. We show that such a probability shares with the frequentist p-value the
property of uniformity under the null hypothesis. This result holds asymptotically, when
the number of observations available for each test is large enough. Our approach is based
on the observation that uniformity under the null hypothesis (as p-values are assumed to
be) is the main property used in the multiple testing procedure developed by Benjamini
and Hochberg (1995). We are then able to use the posterior probability, defined as an
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input to this procedure, in the same spirit as a p-value. We note that such a probability
can also be seen as a test statistic from which the distribution under the null hypothesis
is known. As a result, it can also be used in any extension of the Benjamini-Hochberg
procedure, providing a control of the False Discovery or False Negative Rate.
Motivated by the case of microarray data, where the number of observations per gene is
small, we show in the third chapter that the uniform property holds in a non-asymptotic
manner, under a non-informative or a conjugate gamma model. A goodness of fit study
on several microarray datasets is performed as well as an extended simulation study. This
gamma model is extended in the fourth chapter to a multiplicative random effect ANOVA
model, taking the arrays and dyes effects into consideration. Other models, such as in-
verse Gaussian models are also considered in the fifth chapter. In such cases, the uniform
property of the posterior probability considered can be observed empirically when the
sample size is small. Results using these models are very encouraging. A case study is
presented in Chapter 6 using three microarray datasets resulting from a collaborative
study between the Universities of McMaster and Waterloo. The methods developed in
this thesis are then applied and results are compared. Our future work is described in the
last chapter, and a brief discussion of the work proposed in this thesis is finally included.
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Chapter 1
Some background on microarray
data
Genetics, as practiced for most of its history, has been a science that deals with the trans-
mission of traits from parental organisms to their offsprings. In 1944, molecular biology
was born, when Oswald Avery (Oswald, Avery Colin & McCarty (1944)) discovered that
chromosomes are composed of a polymer called deoxyribonucleic acid (DNA). Since then,
molecular geneticists are able to approach the subject from its foundation: the molecule.
Instead of examining phenotypic characters, molecular geneticists examine genes, study-
ing their chemical structure, their activity and regulation. In the past decades, molecular
approaches to genetics have become more and more sophisticated and recent advances
in genome sequencing are opening whole new approaches to understanding the regula-
tion and function of genetic material. Today, with the availability of complete genome
sequences of numerous organisms, thousands of genes have been identified. The new task
of molecular biologists is to understand the roles of each gene in the genome. Microarray
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technology can provide a partial answer to this question by measuring and comparing
the expression of thousands of genes simultaneously, under two conditions. This new
technology has also drawn the attention of statisticians: the amount of data available,
the experimental design, the high variability, the significance of the results are all issues
that need to be treated carefully.
In this chapter, we first review some basic terminology used in molecular biology. For a
more detailed introduction, refer to the book Molecular Biology (Weaver (2002)). The
second section provides a brief overview of DNA microarray technology and finally, the
statistical issues associated with gene expression data are presented in the last section.
1.1 Some terminology and motivation
At a microscopic level, every living organism is composed of cells. Humans, for example,
are composed of about 10 trillion cells, divided into about 200 types, each specialized for
such distinctive functions as memory, sight, movement or digestion. Despite the diversity
of their functions, all cells in an organism share a common fundamental property: the
storage of the genetic information inherited from the gametes. This genetic material is
maintained in a three dimensional structure: DNA. How genetic information is replicated
and transmitted from cell to cell and organism to organism is a question that is central
to all of biology. First, each trait of an individual is determined by a pair of inherited
factors called genes with one gene copy (an allele) being inherited from each parent.
The role of the genes in the cell is crucial: genes replicate faithfully, they direct the
production of proteins and they accumulate mutations allowing evolution. In order to
understand how genes work, one should examine their molecular composition. Most
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genes are made of DNA, composed of a double helical structure (two DNA strands wound
around each other). Each DNA strand is composed of linked nucleotides, made of three
elements: a phosphate, a deoxyribose sugar and a nucleic acid base. There are four
distinct bases: adenine (A), guanine (G), cytosine (C) and thymine (T). The two DNA
strands are complementary, in the sense that wherever we find an A in one strand, a T is
present in the opposite one. Similarly, the base G is complementary to the base C. This
complementarity allows DNA to be replicated faithfully. Finally, the two DNA strands
are held together by hydrogen bonds: two between A-T basepair and three between G-C
basepair.
Figure 1.1: Double helix DNA structure
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The double helical structure of DNA is illustrated in Figure 1.1.
As we saw earlier, genes direct the production of polypeptides, or proteins. This is
a really crucial step in the cell development since protein activity directly determines
the characteristic features (phenotype and functions) of cells (eg: cancer and normal
cells). The process by which a gene product (RNA or polypeptide) is made is called gene
expression, and involves two steps, called transcription and translation. These two steps
are required to make a protein from the information carried in genes. In the transcription
process, an enzyme called RNA polymerase makes a copy of one of the DNA strands,
leading to the formation of messenger RNA (mRNA).
Figure 1.2: Figure (a) represents DNA before transcription. Figure (b) represents the
transcription step: the DNA should unwind so that one of its strands can be used as a
template to synthesize a complementary strand.
This step is illustrated in Figure 1.2. In the translation step, the mRNA carries the
genetic instructions to the cell’s protein factories, called ribosomes. The transcription
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Figure 1.3: The central dogma of molecular biology
and translation steps are often referred as the central dogma of biology and they are
illustrated in Figure 1.3 (picture: Andy Vierstraete, 1999).
Since most differences in a cell state (eg: cancer cell versus normal cell) are correlated
with changes in mRNA levels of genes, and since the pattern of genes expressed in a
cell is characteristic of its present state, it is of high interest to quantify the amount of
expression of a set of expressed genes under two or more cell conditions.
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1.2 Microarray technology
Gene expression can be measured during the transcription or translation process of a
protein synthesis. To date, attention has focused primarily on monitoring changes at
the transcriptional level, although protein arrays have recently been developed (Haab,
Dunham & Brown (2001)). Although several types of microarray systems exist, we focus
our attention on cDNA arrays, developed in the Brown & Botstein labs of Stanford.
Using this type of array, gene expression can be followed using fluorescent cDNA probes
and then measured using a scanning confocal laser microscope.
A microarray experiment can be divided into several stages, briefly described here. For
a more detailed description of each of the following steps, we refer to Nguyen, Arpart,
Wang & Carroll (2002).
1. Preparation of the biological samples: mRNA is extracted from cells grown under
the two conditions studied.
2. cDNA synthesis: Complementary DNA (called cDNA) is prepared from each of the
RNA samples. This is done using an enzyme called transcriptase which is able to
synthesize a strand of DNA complementary to the mRNA sequence (A replaced by
T, T by A, G is replaced by C and C by G).
3. Labeling of the cDNA samples: Fluorescently tagged nucleotides are used for the
cDNA synthesis. Each cDNA sample is labeled with a different fluorescent dye
(a red-fluorescent dye Cy5 for one sample and a green-fluorescent dye Cy3 for the
other). Then, the two fluorescent samples are mixed together. This is called the
”probe”.
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4. Array fabrication: after choosing the set of genes that will be investigated, the
DNA sequences corresponding to the genes are printed onto a glass slide (array).
Thus, each spot of the array contains a particular DNA gene sequence that, when
denatured, can base-pair with a complementary cDNA, in the hybridization step.
5. Hybridization: this term refers to the binding of two complementary DNA strands
by base pairing. Both the DNA on the array and the cDNA are denatured. The
labeled cDNA is spread on the array and by using the complementarity between
the labeled cDNA and the DNA spotted on the chip, some of the labeled cDNA
binds to specific complementary sequences. As an example, consider a particular
spot on the array. This spot contains the DNA sequence coding for a particular
gene, say gene A. If gene A is expressed under at least one of the two conditions,
cDNA coding for that particular gene will be present in the labeled cDNA solution
and the cDNA sequence (labeled in green or red) for gene A will bind to the DNA
sequence contained in the spot studied. When the hybridization process is over,
unbound cDNA is washed off the array.
6. Construction of the raw data: The microscope slide containing the microarray is
placed inside a darkened box. Inside the box, it is scanned with a green and a
red laser to detect the bound labeled cDNA. Then, for cDNA arrays, the raw data
consists of two images, one obtained from the Cy3 dye and one obtained from the
Cy5 dye.
7. Image processing: this step allows us to obtain numerical data from the raw data
obtained in the previous step. First, for each raw image, the location of each spot
on the array is obtained using some image analysis techniques. Then, for each spot,
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an estimate of the spot and background intensity is produced, based on the mean or
median intensity values of the pixels in the spot area and in the background region.
At the end of this step, we obtain background and spot intensities for each spot on
the array and for each of the two dyes.
8. Background correction: most of the statistical analysis are based on the background
corrected intensities. For each spot and for each dye, we subtract the background
intensity from the spot intensity to obtain the final dataset. For an experiment
involving m arrays and n genes (spots), we obtain two matrices: R=(rij) and
G=(gij) corresponding to the red and green corrected intensities for gene i and
array j.
1.3 Statistical issues in a microarray experiment
As we have seen, a microarray experiment involves a large number of complex procedures.
The raw data are then generally influenced by systematic experimental variation, leading
to noisy and biased measurements. To the extent the sources of variation are understood,
they should be carefully controlled in a well designed experiment. However, in order to
remove extraneous sources of variation that affect the measured gene expression levels,
a normalization procedure must be applied to the data. Once the data are normalized,
some statistical problems, like the discovery of a pattern of expression over several con-
ditions, or the identification of differentially expressed genes, can be explored.
In addition to the high variability of the data, the cost of the technology allows the scien-
tist to use only a limited number of arrays in an experiment, which greatly complicates
the variance estimation. Furthermore, how to model the dependence structure between
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genes remains an open issue in the microarray literature. Certain types of well-designed
experiments, such as microarray time-series data for example, can provide a possible
mean for identification of transcriptional regulation relationship among genes. However,
identifying correlation structure between genes is a difficult task to achieve in most of the
datasets.
1.3.1 Variation and design of experiment
The exact factors contributing to the high variability of gene expression data are not
completely understood yet. They can come from the hybridization conditions, the prepa-
ration of the mRNA samples, the type of arrays used or the labeling procedure. Kerr
& Churchill (2001a), Kerr, Churchill & Martin (2001b), Kerr, Afshari, Bennett, Bushel,
Martinez, Walker & Churchill (2002) studied in a series of three papers the potential
sources of variation that can lead to misleading and biased results. To the extent these
sources are known, they should be incorporated in the statistical model. Several fac-
tors were identified such as the array, dye, treatment and gene effects. The authors also
pointed out a significant dye/gene interaction that seems to be present in most of the
datasets studied: it was observed in multiple datasets that some genes exhibit higher
expression when they are labeled with one particular dye, compared to the other one.
This phenomenon was identified regardless of the sample. If such an effect occurs, the
estimates of relative expression will be biased, leading to a wrong interpretation of the
results. The contribution of Kerr et al to microarray data analysis was really significant,
since they emphasized the importance of the design of the experiment in this particular
context. They also proposed several designs, like the loop design when several factors
of interest are studied, as well as ANOVA models that enable controlling for the sys-
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tematic sources of variation. The most significant aspect of the proposed designs is the
dye-reversal strategy: every experiment (array) should be replicated with the Cy5 and
Cy3 labeling reversed. This strategy is proposed in order to control the possibly high
gene-dye interaction effect and is commonly called a dye-swap experiment. Furthermore,
it allows the design to be balanced with respect to the dyes.
The second major tool allowing a better understanding of the basic variability of gene
expression data is replication. Replication, in a microarray experiment, is divided into
three classes: the subsampling strategy, the array replication and the biological repli-
cation. Subsampling refers to the replication of the spots (genes) on the array. This
practice is commonly used since every gene can easily be spotted at least two times on
the array without any supplementary cost. The array replication refers to the replication
of the hybridization step, on another array, using the same RNA source. This type of
replication allows the estimation of the between-arrays variation. Finally, the biological
replication allows the estimation of the biological variation since this type of replication
samples multiple individuals, through different RNA sources.
1.3.2 Normalization for cDNA microarray data
When the different sources of variation cannot be controlled or estimated through a well
designed experiment, a normalization procedure is required, in order to remove system-
atic effects that may bias the results. Normalization of gene expression data is a very
challenging issue and, although more research is needed, more and more sophisticated
methods are available. However, for any method, the set of genes that should be used
for the normalization must be determined. In the case where a small proportion of genes
are expected to vary in expression between the two mRNA samples, all the genes on the
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array should be used (Yang, Dudoit, Luu, Lin, Peng, Ngai & Speed (2002)). Another
approach is to use a set of housekeeping genes for the normalization. These genes are
expected to be expressed in a constant manner over the two mRNA samples and can pro-
vide a baseline for normalization. The third possibility involves the use of spiked control
sequences. These DNA sequences (in general not genes) are chosen such that we expect
to have equal red and green intensities across the range of intensities. Usually, these
DNA sequences come from an organism different from the one studied. Unfortunately,
this method is very challenging, from a technical point of view, and is not commonly used
in practice.
Depending on the experimental set-up, several methods of normalization can be used.
Yang et al. (2002) proposed three types of normalization procedure: the within-slide nor-
malization, the paired-slides normalization (for dye-swap experiments) and the multiple-
slides normalization. In the first case, the normalization is done separately for each slide
(array). Several approaches can be used, but the most popular one is the global normal-
ization, which assumes that the green and red intensities are related by a constant factor
k. Several methods of estimating the constant k are available (Ideker, Thorsson, Siegel
& Hood (2000)). The second type of normalization applies to the dye-swap experiments
and is similar in spirit to the global normalization. Finally, the last type of normalization
adjusts for multiple array experiments.
We note that most of the normalization methods are applied to the ratio Red/Green of
the expression measurements. Also, many statistical methods are based on the logarithm
of this ratio. Although the logarithm scale has the advantage of reducing the variability
of the data, we believe that some useful information is lost by using such a statistic. For
example, a ratio of 2 can be obtained from very low or very high expressions under both
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treatments. Intrinsic differences exist in the behavior of the gene’s expression between
these two types of situations. Modeling the expression’s intensity allows one to consider
such differences, which the ratio does not. In the next chapters, all the methods developed
will be based on the raw background corrected intensity measurements. We note however
the following point: if it is implicit in the use of microarrays that the measured intensity
is a measure of the abundance of the mRNA in the sample, there may be some situations
where it is not the case. For instance, it is possible that some genes are sequence-related,
like those that codify for a family of proteins, for example. In such a case, a microarray
spot could show mixed mRNA populations (it is also known as cross-hybridization). This
result is not specific, because the intensity is not related with the abundance of a specific
mRNA. As we mentioned, the labeling reaction could also present some bias: some mR-
NAs are more efficiently labeled than others with a particular dye. It follows that low
intensity spots should not necessarily be treated differently.
1.3.3 Some statistical problems
Depending on the set-up of the experiment, a wide range of interesting statistical problems
are associated with microarray data. As we have seen earlier, normalization procedures,
the planning of the experiment (design, sample size) as well as the analysis of factorial
experiments are of high interest.
Tumor classification (Dudoit, Fridlyand & Speed (2002)) is an example of a topic that can
be investigated through microarrays: new/unknown tumor classes can be identified using
some statistical methods like cluster analysis or other unsupervised learning methods.
Discriminant analysis or other supervised learning methods can also be used to classify
the tumors into known classes. Finally, some variable selection methods can provide a
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way to identify a “super gene” (or marker gene) that could characterize the different
tumor classes. In a typical tumor classification problem, the experiment usually involves
a large number of arrays, each of them comparing a specific tumor cell to a normal cell
(Control). For such a problem, the very large number of variables (genes) relative to the
number of observations (tumors) provides an interesting statistical challenge.
Another task is to find a set of genes that behave similarly in various conditions. In such
a case, some unsupervised learning methods, like cluster analysis applied on the genes,
have proven efficiency and many new cluster algorithms are now available.
Finally, in the next chapters, our attention will focus on a question that brings several
interesting statistical problems: the discovery of differentially expressed genes. Basically,
we consider replicated experiments comparing two cell types: a treated one and a control
one. We are interested in finding a set of genes that are expressed significantly different
in one cell type as compared to the other one. If the expression level of the treated
cell is higher than that of the control one, for a specific gene, we say that the gene is
over-expressed. On the other hand, if the expression level of the treated cell is lower than
that of the control one, we say that the gene is under-expressed.
The first problem related to the open question: “which genes are up/down”, is the multi-
ple testing issue (cf Dudoit, Shaffer & Boldrick (2003)). Since we want to make inference
at a gene level, we need to test the null hypothesis that the mean expression level is
equal for the treated and control cell for gene i, for each gene on the array. In practice,
thousands of genes are studied simultaneously and then, thousands of statistical tests are
performed. Since the probability that at least one Type I error is committed increases
a lot with the number of hypotheses, numerous methods have been proposed to control
the Family Wise Type I Rate (FWER), by adjusting the p-values of the tests. However,
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even if these methods allow several hypotheses to be tested simultaneously, they hardly
handle a very high number of tests. Some approaches that minimize the False Discovery
Rate (FDR) have recently been proposed. Instead of fixing the error rate to estimate
the rejection region, these methods propose the opposite approach: fixing the rejection
region to estimate the corresponding error rate. The optimal region is then chosen such
that the error rate is controlled at a specified level. These types of methods have proven
efficiency, increase the power of the tests and can be easily applied in a context where
the number of hypotheses tested is very high.
The second statistical issue with the type of problem studied is the distribution assump-
tion. Most of the work published so far assumes a log-normal distribution or a gamma
distribution (cf Ibrahim, Chen & Gray (2002), Newton, Kendziorski, Richmond, Blattner
& Tsui (2001) and Kerr et al. (2002)) of the expression levels. With the high variability of
the data, there is need for models that allow a greater flexibility and where the parametric
assumptions are lightened. A large number of models have been suggested to identify
differentially expressed genes. Some methods propose a frequentist approach (Kerr et al.
(2002), while some others use a Bayesian framework (Ibrahim et al. (2002), Newton
et al. (2001)) or a mixture of models (Kendziorski, Newton, Lan & Gould (2002)). We
can also find some parametric approaches (Kerr et al. (2002)) and others that are non-
parametric (Efron, Storey & Tibshirani (2001)) or semi-parametric (Newton, Noueiry,
Sarkar & Ahlquist (2003)). We believe that the frequentist approaches are too restric-
tive and that a Bayesian framework provides a more flexible alternative. The use of a
mixture of distributions for the two hypotheses tested can also allow us to obtain a good
approximation of the expected false discovery rate. Our goal for the next chapters is to
construct a test statistic, as robust as possible to the variability contained in the data,
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based on an underlying Bayesian informative model, which is as flexible as possible. A
hypothesis test will be constructed, from the test statistics, minimizing a criterion related
to the False Discovery Rate in a Bayesian context.
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Chapter 2
Multiple testing using posterior
probabilities of half spaces
The main goal of this chapter is the construction of a formal hypothesis test to iden-
tify differentially expressed genes under a Bayesian framework. A null hypothesis of no
difference in the gene expression under two conditions is constructed. Since a test is per-
formed for each gene, it follows that thousands of tests are performed simultaneously, and
multiple testing issues then arise. The aim of our research is to make a connection be-
tween Bayesian analysis and frequentist theory in the context of multiple comparisons by
deriving some properties shared by both p-values and posterior probabilities. Following
the work of Dudley & Haughton (2002) regarding the asymptotic normality of posterior
probabilities of half- spaces, we show that the posterior probability of the one-sided alter-
native hypothesis, defined as a half-space in our case, shares with the frequentist p-value
the property of uniformity under the null hypothesis. This result holds asymptotically,
when the number of observations available for each test is large enough. Uniformity under
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the null hypothesis (as p-values are assumed to be) is the main property used in most
of the multiple testing procedures developed recently controlling for the False Discovery
Rate and the False Negative Rate. We are then able to use this posterior probability as
an input to these procedures, in the same spirit as a p-value.
The first section of this chapter reviews the issues brought by multiple tests. In the
second section, we present the Bayesian framework under which multiple comparisons
are performed. The uniform property of the posterior probability studied is presented in
the third section, as well as a review of the work done by Dudoit et al. (2002). Finally,
the procedure allowing the integration of such a Bayesian quantity into the methods
developed recently is presented in the last section.
2.1 The multiple testing issue
Consider the problem of testing simultaneously n null hypotheses H0i (i = 1, . . . , n). For
each test i, a statistic is constructed from which a p-value, Pi, is derived. We consider here
the test procedure that rejects H0i if Pi ≤ t, for all i = 1, . . . , n and a specified t ∈ [0, 1].
The various outcomes for the n tests can be summarized in Table 2.1, where the numbers
# not rejected # rejected
# true null hypotheses U(t) V(t) n0
# non true null hypotheses T(t) S(t) n1
n-R(t) R(t) n
Table 2.1: Outcomes when testing n hypotheses for a t-dependent test procedure
n0 and n1 of true and false null hypotheses are unknown parameters. The quantities R(t),
S(t), T(t), U(t) and V(t) are all random empirical processes, for a t-dependent rejection
region, from which only R can be observed. The variable V is often referred to as the
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number of false positives, or Type I errors, whereas the variable T represents the number
of false negatives, or Type II errors. The standard methods seek tests that minimize the
Type II error rate (or maximize the power) within the class of tests where the Type I
error rate is fixed at a reasonable level δ. The main concern raised by the multiple num-
ber of tests is that the probability of at least one Type I error (also called Family-Wise
Error Rate or FWER) increases dramatically with the number of hypotheses tested. As
a result, there is the need for a redefinition of the Type I error rate, in the case of multiple
tests, allowing a global control over the n tests of the proportion of errors.
Typical solutions to the problem described can be divided into two approaches. Fre-
quentist approaches usually compute a p-value for each test, that can be integrated into
three main types of multiple testing framework: the single-step procedures, the step-down
and step-up procedures (see Dudoit et al. (2003)). In single-step procedures, the rejec-
tion region of each test is constant and does not depend on the results of tests of other
hypotheses. A well known example of such procedure is the Bonferroni procedure. In
step-down procedures, p-values are ordered from the most significant to the least signifi-
cant, and corresponding hypotheses are considered successively. When one fails to reject
a null hypothesis, no further hypotheses are rejected. An example of such procedure is
the Benjamini-Hochberg procedure (see Benjamini & Hochberg (1995)). Finally, step-up
procedures work in the opposite direction as the step-down procedures, and p-values are
sorted from the least significant to the most significant one.
A review of multiple testing procedures in a frequentist setting, as well as the different
error rates developed can be found in Dudoit, van der Laan & Pollard (2004). It is com-
mon practice now to seek procedures providing a control for the False Discovery Rate
(FDR): the expected proportion of Type I errors among rejected null hypotheses, and the
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False Negative Rate (FNR): the expected proportion of Type II errors among rejected
alternative hypotheses. Using the notation defined in Table 2.1, the False Discovery rate













P (R(t) > 0), (2.1)
where R(t)∨ 1 =max(R(t), 1). A recent and very powerful approach, proposed by Storey
(2002), is to fix the rejection region of the tests (ie, fix the threshold t) in order to provide
an estimate of the FDR, whose expectation was shown to be greater than or equal to




[R(t) ∨ 1]/n (2.2)
where p̂0 is an estimate of p0 ≡ n0/n, the proportion of true null hypotheses. This
estimate depends on a tuning parameter λ such that
p̂0(λ) =
n−R(λ)
(1 − λ)n . (2.3)
Storey (2002) showed how to pick λ optimally in order to minimize the mean square error
of the estimates. We also note here that the estimated FDR presented can be adjusted
for the finite sample case. The FDR-controlling procedure proposed by Storey, Taylor &
Siegmund (2004) can be summarized as follows:
1 : Let δ be the pre-chosen level at which to control the FDR
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2 : For any significance region [0, t], estimate FDR(t) by ˆFDRλ(t) given in (2.2)
3 : Let t∗ = sup{0 ≤ t ≤ 1 : ˆFDRλ(t) ≤ δ} and reject all null hypotheses corre-
sponding to Pi ≤ t∗.
It can be shown that, under convergence assumptions that are easily verified when n
is large enough, the limsup of FDR(t∗) can be controlled at a level δ. Several other
asymptotic results have been proved and we refer to Storey et al. (2004), Genovese &
Wasserman (2002a) and Genovese & Wasserman (2002b) for more details. The well-
known Benjamini-Hochberg procedure (cf Benjamini & Hochberg (1995)) appears to be
a particular case of the procedure defined, with λ = 0. For λ 6= 0, the procedure defined
is equivalent to the Benjamini-Hochberg procedure with n replaced by p̂0n. Storey (2003)
also developed a procedure controlling for the pFDR, referred as the positive FDR (con-
ditioning on the fact that we reject at least one hypothesis) and developed a Bayesian
version of the p-value, referred as the q-value.
The major issue regarding these procedures deals with the estimation of the distribution
of the test statistic under the null hypothesis (in the case of a p-value, assumed uniform
on the interval [0, 1]). In some cases, this distribution may be based on some asymptotic
properties that may not be verified when the number of observations per test is small.
Some methods to estimate the distribution of these statistics under the null hypothesis
have been developed, based on resampling strategies, and we refer for example to Van
Der Laan, Dudoit & Pollard (2004). However, these methods have in general the main
disadvantage of being computationally intensive.
The second type of approach commonly used in practice is defined in a context of
Bayesian, empirical Bayes or random effects models, where a second level of randomness
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is assumed on the parameter of interest. Consider for example the situation where n
subjects are studied, with m observations available for each subject. A hypothesis test
is then performed independently for each subject, based on the set of m observations.
Empirical Bayes methods have proven to be very efficient, particularly in the situation
where the number of observations available for each subject is small or when the number
of subjects is very large. Such methods in the context of microarray experiments (where
the subjects represent the genes) have been used and described in Efron et al. (2001),
Efron (2003), Ibrahim et al. (2002), Newton et al. (2003) and Smyth (2004) for example.
The main advantage of this type of approach is that it allows a subject-specific inference,
through the use of posterior probabilities, without the need of estimating a set of param-
eters for each subject. The parameters of the model are typically estimated using the
data for all the subjects (in an empirical Bayes manner), allowing for a certain sort of
dependence between subjects. Furthermore, the use of a mixture of distributions under
the null and alternative hypothesis respectively accounts for a within-subject dependence.
Recent work, accounting for multiple testing issues, can be found in Muller, Parmigiani,
Robert & Rousseau (2004), who developed a test procedure controlling for the posterior
expected FDR and FNR. In this context, a typical Bayesian measure of significance for
each test is the posterior probability of the alternative hypothesis, closely related to the
well known odds ratio. This probability can usually be computed easily, using the pre-
dictive distribution of the data under the null and alternative hypothesis. This type of
approach has two main drawbacks. First, non-informative models cannot be considered,
since the predictive distribution is typically improper in such a context (however, note
that the use of non-informative prior distributions leads in general to proper posterior
distributions). The second disadvantage is that one-sided alternative hypotheses can-
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not be considered since it is not possible to distinguish one side or the other when the
measure of significance is above a threshold. Some other Bayesian approaches have been
developed, where posterior probabilities are adjusted to account for multiple hypotheses
(see Westfall, Johnson & Utts (1997)). This can be accomplished by calibrating the prior
distribution for the joint parameter space to provide strong control of the family-wise
error rate (FWER). However, this approach has been argued to be overly conservative.
Other methods have been proposed, which provide a weak control of the FWER (see
Shaffer (1999)) or of the probability of a sign error (see Gelman & Tuerlinckx (2000)) but
it remains an open question how multiplicity adjustments should be performed under a
Bayesian framework.
2.2 The Bayesian framework
As we mentioned, Bayesian or random effects models have been extensively used in the
literature to model gene expression data. These types of models are found to be very
good candidates to capture complex patterns of variation in the data, as well as the
relationship existing between their first two moments. Also, even with a small number of
observations per gene, the hierarchical framework allows a gene-specific inference, while
keeping the number of parameters reasonable.
2.2.1 An overview of Bayesian models
Let X
e
be a random sample in Rn, with probability density function f(x
e
|θ), where θ ∈
Θ ⊂ Rd represents the parameter of the distribution. Assuming a distribution with
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density π on Θ enables us to incorporate the prior knowledge we have on the behavior of
the data. Bayesian analysis combines this prior information with the information brought
by the sample into the posterior distribution π(θ|x
e
). Therefore, the posterior distribution
allows us to update our beliefs about θ after observing the sampled data. The posterior




















|θ) is the likelihood of the data. In this case, note that ν represents a sigma-finite
measure on Θ’s space, not involving hyperparameters. In Bayesian analysis, the choice
of the prior is an important step of the inference process. It can be determined in a
subjective way, using approaches such as the histogram approach, the relative likelihood
approach or the CDF determination (Berger (1980)). In situations where little or no a
priori information is available, a non-informative prior is generally used. This type of
prior contains no information about the parameter θ and in practice, the choice of an
improper distribution (one having an infinite mass) is not unusual. However, improper
priors can lead to proper posterior distributions, as we will see in the next section, and
inference about the parameter of interest may not be affected.
One of the main disadvantages of Bayesian models, compared to frequentist ones, is
the computational complexity of the posterior distribution. The use of conjugate priors
requires little computational effort, and their simple parametrization is often a nice al-
ternative to more complex models. In such a situation, the prior-likelihood pair forms a
conjugate family, where the prior and posterior distribution have the same form.
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2.2.2 Definition of the model
Consider a replicated cDNA microarray experiment involving two treatments (T1 and
T2). Let Xij be the intensity (expression) recorded for gene i on array (replication) j
under T1 and Yij be the intensity for gene i on array j under T2, where i = 1, . . . , n
and j = 1, . . . , m. We consider here that the data have been normalized between and
within arrays such that systematic effects have been removed. We assume, for now, that
all the variables are independent. We denote by Xi
e
the random sample (Xi1, . . . , Xim)
corresponding to gene i, and by X
e
the random sample (X1
e
, . . . , Xn
e
). Similarly, we de-
note by Yi
e
the expression of gene i under T2 and let Y
e
represent the complete set of
expression measurements under the second treatment. In the following, we suppose the




of a given gene to be identically distributed, with mean θxi
and θyi respectively. First, consider the two sets of hypothesis, for i = 1, . . . , n :
H0i : Gene i is equally expressed under T1 and T2,
H1i : Gene i is differentially expressed under T1 and T2,
and define for each gene the variable Hi such that Hi = 1 if H1i is true, and 0 otherwise.
These variables are assumed to be distributed according to the Bernoulli distribution with
parameter p. In other words, we assume that for each gene independently, H1i occurs
with probability p and H0i occurs with probability (1 − p). We also assume a specific








are independent, conditionally on their mean θ. Furthermore, we consider
the addition of a mixture of prior distributions on (θxi, θyi) to this model, such that,
conditionally on the indicator variables Hi’s,
θxi ∼ π(.),
θyi|θxi;Hi = 1 ∼ π(.),
θyi|θxi;Hi = 0 ∼ δθxi(θyi),
where δ() is a Dirac δ-function. Under the alternative hypothesis that the gene is dif-
ferentially expressed under the two treatments, the marginal means are considered to be
independent of each other. Under the null hypothesis, they are assumed to be identical.














































where θxi and θyi are assumed to be independent. We note that the dependence of the
gene expression between the two treatments is addressed by assuming a mixture of mod-
els under the null and alternative hypothesis. However, the independence assumption
between genes may not be completely realistic in practice. This concern is partially
addressed by the fact that empirical Bayes techniques are used to estimate the hyperpa-
rameters of the model. In this case, these parameters are estimated using the whole set
of data. However, how dependence between genes should be modeled remains an open
question in the literature.
Under such a model, we can rewrite the hypothesis H0i and H1i as
H0i : θxi = θyi,
H1i : θxi 6= θyi.















































































2.3 Uniform property of the posterior probability of
half-space, under H0
We present here an interesting result regarding the posterior probability of half-spaces,
obtained by Dudley & Haughton (2002). Note that this result is first presented in its
general form, and we do not consider the Bayesian framework defined in the previous
section yet. Connection with this model will be made in the next section. Consider Θ as
an open subset of an Euclidean space Rd. A half-space of Θ is defined as
A = {θ ∈ Θ : θ.υA ≥M}, (2.6)
where υA ∈ Rd, |υA| = 1, θ.υA represents the dot product of θ and υA and M ∈ R. The
boundary hyperplane of A is defined as
∂A = {θ ∈ Θ : θ.υA = M}. (2.7)
Now, to introduce the next theorem, we consider the set P = {Pθ : θ ∈ Θ} of family
of laws dominated by a σ-finite measure µ on a sample space (X ,B). Let f(x, θ) be
the density (dPθ/dµ)(x), x ∈ X , θ ∈ Θ. We take 0 ≤ f(x, θ) ≤ ∞. We consider a set
of iid random variables, X1, X2, . . . with values in X and with some law P ∈ P. We
denote xm
e
= (x1, . . . , xm) and Xm
e





the maximum likelihood estimate of θ ∈ Θ.










Figure 2.1: Illustration of the hyperplane and half-space in the case Θ = R2+





) the maximum likelihood estimate of θ in ∂A. If we consider the null















We consider also that a prior probability is given on Θ with continuous density π0(θ) > 0
for all θ and
∫
Θ
π0(θ)dθ = 1. The posterior distribution of θ on Θ is then defined as πx,m.
Under such a framework, the following theorem can be stated
Theorem 2.1. Under some regularity conditions, for all ε > 0,
Φ(Qm)
1 + ε
≤ πx,m(A) ≤ (1 + ε)Φ(Qm), for m large enough, almost surely,
where Φ is the standard normal distribution function and where πx,m(A) = P (θ ∈ A|x1, . . . , xm).
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∆m if θ̂m /∈ A,
−√∆m if θ̂m ∈ A.
It follows that if θ ∈ ∂A,
πx,m(A) converges in distribution to U , as m→ ∞,
where U ∼ U(0, 1).
The regularity conditions of this theorem are stated in the following:
(A1) Define LLm(θ) as being the log likelihood function. There is a θ0 ∈ Θ, called the
pseudo-true value of θ, such that for every neighborhood N of θ0, there is a κ > 0
such that almost surely for m large enough, supθ/∈NLLm(θ) < supθ∈NLLm(θ)−mκ.
(A2) For θ in a small enough neighborhood W of θ0, the function f(x, .) is strictly positive
and C2 in θ for P -almost all x, and the P -Fisher information matrix E(θ) :=
{Eij(θ)}di,j=1 := {EP (−∂2logf(., θ)/∂θiθj)}di,j=1 exists and is finite, strictly positive
definite and continuous in θ.
(A3) Let Pm := (δX1 + . . . + δXm)/m, with δx(A) :=
 
A(x). For some neighborhood W
of θ0, the class FW := {−∂2logf(., θ)/∂θiθj} of functions for θ ∈ W , i, j = 1, . . . , d,
is a Glivenko-Cantelli class for P ; this implies that supg∈FW |
∫
gd(Pm − P )| → 0
almost surely as m→ ∞.
Note that condition A1 can be found from sufficient conditions for consistency of approx-
imate MLE’s. Furthermore, conditions A2 and A3 hold for exponential families. These
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conditions ensure the existence of θ̂, for m large enough.
The proof of the first part of the theorem is given in Dudley & Haughton (2002). The
second part of the theorem is a direct corollary and the proof is straightforward. The
theorem is based on the fact that if θ ∈ ∂A, the likelihood ratio statistic, ∆m = ∆(Xm
e
),
is distributed asymptotically according to a Chi-square distribution with 1 degree of free-
dom (since the dimension of the boundary hyperplane is equal to d − 1). This implies
that
√
∆m is distributed as |Z|, where Z has a standard normal distribution. Adding a
nearly random sign to ∆m, through the variable Qm, brings us to normality, by symmetry
of the normal distribution. It follows that the random variable Φ(Qm) is asymptotically
uniform on the interval [0, 1]. For the corollary, by letting ε tend to 0, we obtain that
the posterior probability πx,m(A) converges in distribution to a Uniform variable, on the
interval [0, 1]. Note that the variable Qm can be viewed as a signed-root likelihood ratio
statistic, defined in the case of testing the boundary of a half space.
2.4 Using the posterior probability of the one-sided
alternative hypothesis in a multiple testing frame-
work
The aim of this section is to link the results presented in the last section with our problem
of interest. We are presenting here a test statistic, in the Bayesian framework presented
in Section 2.2, from which we can derive, or estimate, the distribution under the null
hypothesis. Doing so, it is then possible to integrate such a statistic into the frequentist
multiple testing procedures described earlier, based usually on frequentist p-values or
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statistics.
Considering a set of null hypotheses H0i : θxi = θyi for each gene i, we propose to use








, Hi = 1
)
, (2.8)
where Hi has been defined in Section 2.2.2. Making the link with Theorem 2.1, we
consider for each gene i the set of iid variables Zi1, . . . , Zim, such that Zij = (Xij, Yij)
for j = 1, . . . , m. Gene expression being a positive measure, the spaces are defined as
Rd = Θ = R2+, the set of positive real numbers on a space of dimension 2. Note
that during the background correction step, genes with negative expression are usually
flagged and removed from the analysis, or set to a very low expression value. Without
loss of generality, we take Ai = {(θxi, θyi) ∈ Θ : θxi ≥ θyi}, with boundary hyperplane
∂Ai = {(θxi, θyi) ∈ Θ : θxi = θyi}. In this case, the half-space Ai represents the space
of the one-sided alternative hypothesis for gene i, whereas the boundary hyperplane ∂Ai
represents the space covered by the null hypothesis. Applying Theorem 2.1, we then
obtain the following Corollary:
Corollary 2.1. Under the regularity conditions of Theorem 2.1 and under the null hy-
pothesis (given Hi = 0),
pi converges in distribution to U , as m→ ∞,
where U ∼ U(0, 1).
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Defining the probability pi given Hi = 1, whereas the result of the corollary is given
conditionally on Hi = 0 may seem a little bit confusing at first. To make our idea clear,
we note that the model being used here is the model defined under Hi = 1, where it may
happen that θxi and θyi coincide, according to the framework under which Theorem 2.1
has been stated. Conditioning on Hi = 1 in the definition of the probability pi emphasizes
the fact that under the conditions of Theorem 2.1, we do not have a model which has
an atom at the boundary. However, the result of the Corollary can also be applied to
the model in which we do have an atom at the boundary. Since we are looking at the
distribution under Hi = 0, the proportion (1− p) = P (H0i) is not of interest in this case.
However, this quantity will be used in the multiple testing procedure, as we will see next.
Two main points motivated our work. First, models using p-values are restrictive
in many aspects, but offer in the other hand the advantage of providing a control of
frequentist error rates, ie. that do not depend on the data. Inversely, Bayesian theory
brings an attractive flexibility to the models, but the control of posterior error rates
can be criticized (see the Discussion provided in Chapter 8). Motivated by the result
obtained in Corollary 2.1, we can use the probability pi in the same spirit as a p-value,
in the FDR-control procedure described in Section 2.1. For example, if one wants to use
the Benjamini-Hochberg procedure, the following steps are required:
1. Compute the probability pi for each gene i. This probability can be easily com-
puted numerically, using procedures such as Monte Carlo, as long as the posterior
joint density function of the parameters θxi and θyi is known under the alternative
hypothesis.
2. Adjust the probability pi by computing p
∗
i = min(pi, 1 − pi). This step allows us
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to obtain a probability p∗i having the same interpretation as a p-value, in the sense
that we reject the null hypothesis for small values of p∗i . Using the original pi would
require to reject the null hypothesis for small or high values of pi. Note that now,
the probability p∗i is asymptotically distributed according to a Uniform variable, on
the interval [0, 1/2], under the null hypothesis.
3. Order the n adjusted probabilities such that p∗(1) ≤ . . . ≤ p∗(n)




iδ = max{1 ≤ i ≤ n : p∗(i) ≤
δi
2n(1 − p̂)}, (2.9)
δ represents the control level of the FDR and p̂ is the estimated value of the pro-
portion of true alternative hypotheses in the data.
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Chapter 3
A particularly favorable case for the
half-space approach
In this chapter, we study two cases where the half-space approach described in Chapter 2
is particularly favorable. Under a general scale model associated with a non-informative
prior distribution, or under a gamma conjugate model, we show that the uniform property
of the posterior probability pi holds not only asymptotically, but for any values of m. In
the first case, the uniformity holds exactly, since we show that the probability pi can
be actually written as a conditional p-value. In the second case, the uniformity holds
only approximately, under some conditions easily satisfied in microarray experiments.
The approach described in Section 2.4 is then particularly favorable in the context of
microarray data, this case representing the perfect illustration of a large number of tests
(large n) with a small number of observations per test (small m). As we show in this
chapter, the use of the posterior probability pi provides advantages over traditional p-
values (parametric or non-parametric), especially when m is small.
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The first section of this chapter deals with the special case m = 1, in a generalized
scale parameter model. The case of the gamma conjugate model is treated in the second
section. Section 3 provides an application of the methodology proposed in section 2.4, for
the gamma model, to microarray gene expression data. A simulation study is performed
in the last section, presenting a comparison of the performance of our proposed method
with some parametric and non parametric p-values, as well as with another Bayesian
approach.
3.1 The non-informative case
In this section, we show that under some conditions on a generalized-scale parameter
model associated with a Jeffrey’s prior, the posterior probability considered can be seen
as a conditional p-value, given one of the two observed samples. We consider here the
case where m = 1. Note that in the case of microarray data, it is standard to spot each
gene several times (usually two to three times) on the cDNA arrays, in a consecutive way.
In many statistical methods available to analyze this kind of data, it is advised to take
the mean of the expression for each gene and each treatment. The dataset obtained has
effectively only one observation per gene, if no biological replication is available, for each
condition, as stated in the next theorem. Following the notation defined in Section 2.2,
we note here that the vector Xi
e
is replaced by the variable Xi, and similarly that the
vector Yi
e
is replaced by Yi.
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Theorem 3.1. If the density f(.) and the prior π(.) satisfy the following:





ii) π(θ) ∝ 1/θ




, Hi = 1), can be written as
pi = P (Xi ≤ xi | Yi, Hi = 0).




























































































= P (Xi ≤ xi | θyi = θxi).




π(θyi|yi)P (Xi ≤ xi | θyi, Hi = 0)dθyi,
= P (Xi ≤ xi | Yi, Hi = 0).
First, note the symmetry of the result presented here: we showed that pi = pi(xi, yi) =
P (Xi ≤ xi | Yi, Hi = 0), which is equivalent to pi(yi, xi) = P (Yi ≤ yi | Xi, Hi = 0).
This theorem implies that under the conditions i) and ii) stated above, the posterior
probability of the alternative hypothesis can be written as a p-value, conditionally on
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the observed value of Yi. A conditional p-value being uniformly distributed under the
null hypothesis, as a p-value is, it is then relevant to integrate this probability into
the multiple testing procedures presented in the last chapter. In this case, note that
the uniform property holds not only asymptotically, but also for m ≥ 1. Furthermore,
the uniform distribution for m = 1 is not an approximation of the distribution of the
probability pi under H0, but represents its exact distribution.
3.2 An extension of the uniform property to the in-
formative case




(i = 1, . . . , n)
from Rm. We suppose here that the hierarchical framework describing the data is the















Xij|θi ∼ G (α, α/θi) ,
Yij|θi ∼ G (α, α/θi) ,
























Xij|θxi ∼ G (α, α/θxi) ,
Yij|θyi ∼ G (α, α/θyi) ,
1/θxi ∼ G (α0, αν) ,
1/θyi ∼ G (α0, αν) ,
(3.2)
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where θxi and θyi are assumed to be independent. Note that here, the gamma distribution
is parameterized such that E[Xij|θxi] = θxi (and similarly for E[Yij]). In such a model, a
set of hyperparameters, denoted (α, α0, ν), is present. We consider here the hyperparam-
eters of the distribution to be the same for X and for Y . In practice, we observed that
such an assumption does not have any serious impact on the fit provided by the model.
However, note that a generalization of this model, where the shape of the data is allowed
to vary across each treatment, array and dye is presented in the next chapter. In the ab-
sence of prior knowledge that would allow us to fix the hyperparameters to some specified
values, they need to be estimated. An empirical Bayes approach can be used, and the
hyperparameters are set to maximize the predictive distribution of the data defined in
(2.5), in a spirit similar to a maximum likelihood approach. The probabilities pi actually
used are then calculated using estimates of the hyperparameters from all the data, and
we will assume the data set to be large enough (ie n large) that the hyperparameters
are essentially known. Note that despite the fact that data are used twice, to estimate
the parameters and to compute the posterior probability, the type of model considered
here is more flexible than any model considering θ as being fixed. Furthermore, the set
of parameters to be estimated is small.
Theorem 3.2. Under the model (3.1), (3.2) above, the probability pi defined in (2.8) can
be written as
pi = P (αmX̄i + ξi ≤ αmx̄i + αν|Yi
e
, Hi = 0),





Furthermore, suppose the following conditions are satisfied:
i) α0 is a positive integer,
ii) for all β > 0.5, the βth quantile of αmX̄i + ξi, given Ȳi and Hi = 0, exceeds M with
probability at least 1 − ε (with respect to the distribution of Ȳi); the constant M is
a specified positive number much larger than αν, and ε is a specified small positive
number.
Then, pi is approximately uniformly distributed under H0i on the interval [0, 1].




































xmα+α0−10 exp (−x0/θyi) dx0.
By noting that under the null hypothesis, mX̄i|θyi ∼ G(mα, α/θyi), and by defining a
new variable ξi, independent of X̄i, such that ξi|θyi ∼ G(α0, 1/θyi), we finally get
A(θyi) = P (αmX̄i + ξi ≤ αmx̄i + αν | θyi, Hi = 0).
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)P (αmX̄i + ξi ≤ αmx̄i + αν | θyi, Hi = 0)dθyi,
= P (αmX̄i + ξi ≤ αmx̄i + αν | Yi
e
, Hi = 0). (3.3)
To prove the second part of the theorem, we need to show that for all β ∈ [0, 1], P (pi ≤








), it suffices to prove this result
for β > 0.5. Here, we actually show that P (pi ≤ β|Ȳi, Hi = 0) ' β. First, we note
that g(w|ȳi) and h(w|ȳi), the probability density functions under the null hypothesis of















(w + αmȳi + αν)
2mα+2α0
wmα+α0−1.
Furthermore, by defining qβ(ȳi) as the βth-quantile of the variable αmX̄i + ξi under H0i
and given Ȳi, and by defining the following function










2 (αmȳi + αν)
mα+α0
×F (qβ(ȳi), mα + α0 − 1, 2mα+ 2α0, αmȳi + αν) , (3.4)
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×F (qβ(ȳi) − αν,mα− 1, 2mα+ α0, αmȳi + αν).
By using the fact that, for all k,












and that under condition ii), (qβ(ȳi)−αν)/qβ(ȳi) is approximately 1 with high probability,
we can rewrite (3.4) as
β ' Γ(2mα + 2α0)
Γ(mα + α0)
2 (αmȳi + αν)
mα+α0
×F (qβ(ȳi) − αν,mα+ α0 − 1, 2mα + 2α0, αmȳi + αν) . (3.5)
Also, we note that for any α0 integer, and for a < b, we have the following relation











F (T, a− α0, b− α0, c),
where a(k) = a(a− 1) . . . (a− k + 1). By using this relation in (3.5) and using condition
ii), we finally obtain
β ' P
[
pi ≤ β|Ȳi, Hi = 0
]
.
The fact that under the conditions of the above theorem, pi can be written in the
form (3.3) does not imply that it is an exact p-value. This is partly due to the fact that
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the quantity αν cannot be seen as an observed value of the variable ξi, since it does not
depend on the observed data. However, the quantity αν represents the expected value of
ξi. The second part of the theorem shows that the probability pi can be approximated
in probability under the null hypothesis by a uniform distribution. Again, note that this
result was not proven asymptotically, but for any value of m. As in the previous section,
this statement allows us to use the quantity pi in the spirit of the p-value, in some multiple
testing procedures that require the uniformity under the null hypothesis. We note that
these theorems can find very good applications in any area where multiple testing is an
issue, and in particular, microarray data. In this case, we also note that assumption ii) of
Theorem 2 is easily verified in practice, as illustrated in Section 3.4.1. This assumption
is related to the magnitude of the gene expression and in general, the accuracy of the
approximation increases with the level of expression of the gene. Assuming α0 an integer
does not have a great impact on the model and on the posterior probabilities, as we will
see in the next sections. We note that the case α0 = 0 is treated in Theorem 3.1 and in
this case, the posterior probability is exactly uniformly distributed under H0i.
3.3 Application: Goodness of fit of the conjugate
gamma model for microarray datasets
In this section, four microarray datasets are studied, generated from three different
sources. The goal here is not to apply the method proposed to these datasets, but to
evaluate the goodness of fit of the conjugate gamma model presented in the last section.
The motivation behind this goodness of fit study is to show that the method we proposed
can really be applied in practice. The first dataset, denoted TCDD, has been previously
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analyzed in Kerr et al. (2002). This experiment studies a compound (TCDD) known to
induce a wide range of biological and biochemical responses, including gene induction.
Two types of cells are studied in the experiment: a control one and a TCDD-treated cell
line. The experiment was conducted over 6 arrays, with the same set of n = 1907 genes
probed on each array, in a “triple dye-swap” experimental design. For now, we ignore the
design component of the experiment and consider the 6 arrays as being m = 6 replications
of the experiment. The design of this experiment is described in table 3.1. The second
Dye1 Dye2
Array 1 Treatment Control
Array 2 Treatment Control
Array 3 Control Treatment
Array 4 Treatment Control
Array 5 Control Treatment
Array 6 Control Treatment
Table 3.1: Design of the experiment
dataset, denoted DBLFLIP, is a sample data available with the R library MAANOVA,
developed by the Jackson Laboratory (cf Kerr et al. (2002), Kerr & Churchill (2001a) and
Kerr et al. (2001b)). This experiment is a four-array double dye swap experiment and
the design is very similar to the one of the TCDD data. In this experiment, 14593 genes
are studied and each gene is spotted twice on each array. The third and fourth datasets,
denoted COLD and FIELD respectively, come from an experiment conducted at the Uni-
versity of Waterloo. This experiment is described in detail in Chapter 6 and contains
4896 genes, printed 3 times on each of six arrays, according to the design presented in
Chapter 6, Table 6.2. Note that the median intensity of the three adjacent spots were
taken. These two datasets represent two different treatments assigned to the plant organ-
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ism Thellungiella Salsuginea. Throughout this section, the intensities corresponding to




respectively. Plots of the raw
data log(X) versus log(Y ) for these four datasets are presented in Figures A.1, A.2, A.3
and A.6.
We note that the datasets have been first normalized independently for each array using
the LOWESS procedure (cf Yang et al. (2002)), described in Chapter 6. Furthermore, an-
other data normalization process needs to be performed, in order to calibrate the signals
from different channels and arrays to a comparable scale. Several methods are available,
like the use of ANOVA models for example. A review of the normalization procedure
used in the case study is provided in Chapter 6. For the current chapter, a simple trans-
formation was applied to the data, so that the mean intensity for each array and for each
dye is the same. Furthermore, in order to avoid any bias due to a strong treatment-dye
effect, we transform the data such that the ratios of the means (Treatment/Control) are
equal for each of the two dye combinations (Dye1/Dye2 and Dye2/Dye1). In particular,








the normalized dataset. For
each gene i, we denote by ȳ1
(i) and ȳ2
(i) the control means for Dye1 and Dye2 respec-
tively. Similarly, we denote by x̄1
(i) and x̄2





(i) are similar and refer to the original dataset. The










for all i = 1, . . . , n. By letting ∆(i) = log(v̄1
(i))− log(ū2(i))− log(v̄2(i))+ log(ū1(i)), we can





































) for Dye 1
satisfy (3.6). To see how well the gamma conjugate model fits the data, we chose to plot
the histogram of the data (on the log-scale) versus the predictive density function (on the
log scale) m(x
e
), as we can see in Figure 3.1. This was done separately for the treatment
and control data and only the results regarding the treatment are presented here (similar
results were obtained regarding the control cases). We can see that the shape of the data
varies a lot from one dataset to another, which confirms the fact that microarray data
strongly depend on many factors that may be specific to laboratories or to the organism
studied. As we can observe, the histograms of the TCDD and COLD datasets suggest
that data may be adequately described by a mixture of models. However, the difference
between the transformed and untransformed data (plots not shown here) does not suggest
that this mixture can be explained by any effects due to the dye, array or treatment. We
can see that the fit provided by the conjugate gamma model is not bad, considering the
shape of the data, and considering that the predictive distribution we obtain is unimodal.
































































Figure 3.1: Histograms versus predictive density function for the four datasets using the
gamma conjugate model (log-scale)
and we will see in Chapter5 that the fit to the FIELD dataset can be greatly improved
by considering another type of model. Finally, note that the estimated hyperparameters
of the model for each of the data are presented in Table 3.2. These parameters were
obtained numerically, using a Newton-Raphson algorithm. Note that in the case of the
data studied, this algorithm appeared to be very stable and seemed to converge to a
global optimum (as observed in the simulations, where the estimated parameters were
closed to the anticipated values).
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Dataset α α0 ν p
TCDD 10.714 0.831 79.58 0.018
DBLFLIP 9.796 1.138 33.78 0.00143
COLD 5.814 0.891 210.1 0.1487
FIELD 5.309 0.9579 325.83 0.2193
Table 3.2: Estimated hyperparameters of the gamma conjugate model for the three
datasets
3.4 Simulation study
The advantage of working with simulated datasets in the context of a mixture of models
is that we know the true state of each observation. Then, for simulated gene expression
data, we know if each gene is truly differentially expressed or not. This allows us to
compute several types of error rates, and provides us with interesting tools to evaluate
the performance of each of the methods and models tested.
In our case, several parameters may influence the performance of the methodology pro-
posed. In particular, the aim of the simulation study is to provide insights regarding the
influence of the parameters δ (level at which one wishes to control the FDR), p (propor-
tion of differentially expressed genes in the dataset), m (number of replications available
for each gene) and p̂ (estimated proportion of differentially expressed genes).
3.4.1 Simulation design
The performance of the method is measured with respect to five criteria: the observed
False Discovery Rate (FDR), False Negative Rate (FNR), Sensitivity (SENS), Specificity
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(SPEC) and Risk (RISK). Using the notations of Table 2.1, these criteria are defined as
FDR = V/R,
FNR = T/(n− R),
SENS = U/n1, (3.7)
SPEC = S/n0,
RISK = (V + T )/n.
In other words, we define the FDR as the proportion of Type I errors among the null hy-
potheses that are rejected. Similarly, the FNR represents the proportion of Type II errors
among the null hypotheses that are accepted. Of course, very small values of FDR and
FNR are expected. The sensitivity represents the proportion of alternative hypotheses
that have been correctly rejected. It is then a measure of the method’s ability to detect
the differentially expressed genes among the alternative hypotheses. Note that this crite-
rion should be the one under control in multiple hypotheses testing. Unfortunately, the
number of true null and alternative hypotheses being difficult to estimate accurately, this
criterion is extremely hard to control in practice, and we will see in our simulation study
that values greater than 0.8 are rarely obtained. Similarly to the sensitivity, the speci-
ficity represents the proportion of null hypotheses that have been correctly accepted. It
can be seen as a measure of the method’s ability to judge correctly the equally expressed
genes among the null hypotheses. Since the number of genes detected as differentially
expressed is typically very small, it is not rare to obtain values of specificity that are very
close to 1. Finally, the RISK represents the total number of errors (of Type I and II)
among the n hypotheses tested and small values are expected.
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We chose to apply our method using the multiple testing framework described in (2.9)
and we refer to it as the pi method. The probabilities pi are computed using a Monte-




y1, . . . , θ
∗
yK) such that







In the case of the conjugate gamma model, note that the posterior distribution of the
parameter θ is given under the alternative hypothesis by
1/θxi|xi
e
, H1i ∼ G (mα + α0, α(mx̄i + ν)) ,
and similarly for θyi. The probabilities pi are then estimated such that
p̂i = #{i ∈ 1, . . . , K : θ∗xi > θ∗yi}/K.
In this document, note that for readability reasons pi refers to the actual estimated value
p̂i.
In the simulation study, the performance of our proposed methodology is compared with
three other methods: two frequentist methods using p-values (one parametric and one
non-parametric method) and one Bayesian method. The first method involves a likeli-
hood ratio test for each gene (noted as LR), under the gamma model described in (3.1)
and (3.2), ignoring the part regarding the prior distribution on θ. In order to avoid any
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over-parametrization problem, the parameters θ were estimated independently for each
gene, using a maximum likelihood approach. The mixture parameter p was set to be the
true value under which data were generated. Of course, in reality, this parameter would
be unknown and would need to be estimated. Several problems can be encountered by
doing so since it implies that the parameters θ of the model cannot be estimated indepen-
dently from gene to gene. However, the focus of this simulation study being to compare
the performance of our proposed method with some other ones, we will not comment
more on that point. The second method is a non-parametric Wilcoxon test (unpaired,
noted WILC). In both methods, the p-values obtained are used in the multiple testing
framework described in Section 2.4, similar to the one used for our method.
The third method we use is the one described by Muller et al. (2004). In this paper,
several loss functions were studied. In order to get comparable results across the different
methods, we chose to use the decision rule minimizing a bivariate loss function, represent-
ing the posterior expected FDR and the posterior expected FNR. Using the Lagrangian
method, it was shown that the decision rule minimizing this loss function is equivalent to
the decision rule providing a control of the posterior expected FDR at a level δ. In this
sense, this approach can be seen as the Bayesian version of the methods controlling for
the FDR, and it is then relevant to compare it with our approach. Another interesting
reason for comparing these two methods is that the test statistic used by Muller et al.




), which is the unconditional two-sided version of our probability pi.
Note that this method is referred as the vi method throughout this document. Similarly
to the probabilities pi, the probabilities vi are computed under the conjugate gamma
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) have been defined in (2.5). The estimated posterior ex-








where (d1, . . . , dn) represents the vector of decisions, such that di = 1 if the null hypothesis
H0i is rejected, and 0 otherwise, and where ε is a small positive number avoiding a
division by zero. The quantity D represents the total number of rejected null hypotheses
(D =
∑n
i=1 di). The optimal decision rule rejects all hypotheses with vi > t
∗, where
t∗ = min{s : ¯FDR(s) ≤ δ},
and where δ is the level of control of the posterior FDR.
In the following sections, datasets were simulated according to the conjugate model
described in (3.1) and (3.2). The parameters chosen are identical to those chosen by
Kendziorski et al. (2002), with α = 10, α0 = 0.8 and ν = 91. For each dataset, n = 1000
genes were simulated, with a proportion p of them being under H1 and with m replications
each (values of p and m may change according to the type of simulation and will be
specified later). Each result presented in the next sections is based on 500 simulated
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datasets, and values of the observed error rates FDR, FNR, SENS, SPEC and RISK
are computed as an average over the 500 simulations. Note that standard errors of the
estimated rates are not presented here since for each estimated value x, it is of the order
of (x(1 − x)/500)1/2. In most of the case, standard errors are of the order 10−3. We also
note that here, the condition i) of Theorem 3.2 does not hold since α0 is not an integer,
but we will see that the violation of this condition does not have a serious impact on
the results. The condition ii) of this theorem holds in this example and in microarray
datasets typically. As an illustration, we mention that the minimum average of αmx̄i + ξi
was found to be 4570, over 500 simulated datasets with m = 10 and p = 0.1.
3.4.2 Influence of the controlled FDR level δ
In this section, we study the influence of the controlled FDR level δ on the perfor-
mance of the methods. This section also allows us to have a global appreciation of the
performance of the methods with respect to each others in terms of the different error
rates. We simulate here datasets with m = 10 and p = 0.1. Values of δ varied as
δ = (1%, 2%, 3%, 4%, 5%). Results are presented in Table 3.3. Regarding the False Dis-
covery Rate, note that we expect values as close to δ as possible for the four methods.
The first thing that we observe is that our proposed method is able to provide an excellent
control of the FDR with values not exceeding the level of control. The performance of
the vi method is also very good, but values of FDR are slightly over the level of control.
The Wilcoxon test provides the lowest values of FDR, but does not control it as well
as the two Bayesian methods. Finally, the likelihood ratio test does not perform well,
with values of FDR systematically over the level of control by 1% to 2%. Regarding
the False Negative Rate, the performance of the two Bayesian methods is identical and
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Error Rate Method δ = 1% δ = 2% δ = 3% δ = 4% δ = 5%
pi 0.010 0.020 0.030 0.039 0.048
FDR vi 0.012 0.023 0.033 0.043 0.053
LR 0.017 0.032 0.048 0.063 0.078
WILC 0.008 0.016 0.024 0.034 0.043
pi 0.023 0.022 0.021 0.020 0.020
FNR vi 0.023 0.021 0.021 0.020 0.020
LR 0.026 0.023 0.022 0.021 0.021
WILC 0.029 0.027 0.025 0.024 0.024
pi 0.787 0.800 0.807 0.814 0.819
SENS vi 0.791 0.803 0.811 0.818 0.822
LR 0.764 0.785 0.797 0.805 0.811
WILC 0.732 0.754 0.767 0.776 0.784
pi 0.999 0.998 0.997 0.996 0.995
SPEC vi 0.999 0.998 0.997 0.996 0.995
LR 0.999 0.997 0.995 0.994 0.992
WILC 0.999 0.999 0.998 0.997 0.996
pi 0.022 0.022 0.022 0.022 0.022
RISK vi 0.022 0.022 0.022 0.022 0.022
LR 0.025 0.024 0.024 0.025 0.026
WILC 0.027 0.026 0.025 0.025 0.025
Table 3.3: Error rates for the simulation study with respect to the level of FDR control
δ. Data were simulated with p = 0.1 and m = 10.
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both provide the lowest rate compared to the other two methods. The likelihood ratio
test performs also reasonably well. However, the Wilcoxon test gives the highest FNR,
which is the price to pay for the low rate of false discoveries. Regarding the sensitivity,
we can see again that the two Bayesian methods give the best performance, with slightly
better rates for the vi method. Again, the likelihood ratio test performs well and the
Wilcoxon test provides the lowest rate. Regarding the specificity, all methods perform
very well, with slightly lower rates for the likelihood ratio test. Finally, in terms of RISK,
the performance of the two Bayesian methods is very good, with an average of 2.2% of
errors among the 1000 tests. The performance of the likelihood ratio and Wilcoxon tests
is also good, but the RISK is higher than for the Bayesian methods.
Regarding the behavior of the methods with respect to δ, we observe results that
could be predicted. As we could expect, the False Negative Rate acts in the opposite
way to the FDR, and values of FNR decrease with δ. Regarding the sensitivity, we note
that whenever δ decreases, the number of detected genes should also decrease. Since the
number of positive genes remains constant for any value of δ, we observe an increasing
trend for this criterion when δ increases. The same argument can be applied to the
specificity: since the number of correctly judged negative genes should increase with δ,
we observe an increasing trend of this criterion with δ. The behavior of the RISK with
respect to δ is harder to predict since the number of false negative and the number of
false positive move in opposite directions with respect to δ. For the Bayesian methods,
we observe a constant RISK over the values of δ, meaning that the loss due to the false
discoveries is compensated with an equal weight by a gain in false negative. The likelihood
ratio test and the Wilcoxon test do not behave similarly: it seems that globally, the RISK
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increases with δ for the LR method, whereas it decreases for the WILC method. In this
last case, it may suggest that the gain in terms of true false negative is more important
than the loss in terms of false positives, whenever δ increases.
3.4.3 Influence of p
In this section, we compare the influence of the parameter p on the different error rates
for the four methods. Data were generated with m = 10 and the FDR was controlled at
a level of δ = 5%. Values of p were taken to be p = (0.01, 0.05, 0.1, 0.3, 0.5, 0.7, 0.9). Note
that in microarray data, p rarely exceeds 0.5, but it is interesting to see the behavior of
the methods when p is large. Results are presented in Table 3.4. Note that the same
patterns regarding the performance of the methods with respect to each other occur, and
we will not comment on that since it was done in the previous section.
By looking at the results, it seems that the FDR is difficult to control when p is small.
For all the methods, we note that as p increases, the level of the FDR gets closer to the
level of control δ = 5%. However, our proposed method is the one that seems to be
the least influenced by the small value of p, with values of FDR extremely close to 5%
even when p is as small as 0.05. As expected, the False Negative Rate increases with p,
since the number of rejected hypotheses decreases with p. When p is below 0.7, it seems
that all the methods perform similarly (except the Wilcoxon test, that tends to have a
higher FNR, as we saw in the previous section). However, when p is very high, the vi
method performs significantly better (with an FNR of 38%) than the other ones who all
have FNR values around 44%. Regarding the sensitivity, specificity and RISK, the same
comments can be made as in the last section. However, it seems that all the methods are
influenced the same way by the increase of p. Specifically, sensitivity and RISK increase
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Error Rate Method p = 0.01 p = 0.05 p = 0.1 p = 0.3 p = 0.5 p = 0.7 p = 0.9
pi 0.064 0.048 0.050 0.048 0.049 0.049 0.050
FDR vi 0.101 0.057 0.053 0.051 0.050 0.050 0.051
LR 0.088 0.082 0.079 0.071 0.066 0.062 0.053
WILC 0.044 0.043 0.044 0.045 0.047 0.048 0.049
pi 0.002 0.010 0.020 0.062 0.119 0.212 0.441
FNR vi 0.002 0.010 0.020 0.061 0.116 0.204 0.387
LR 0.003 0.011 0.021 0.063 0.118 0.021 0.440
WILC 0.003 0.012 0.024 0.071 0.131 0.228 0.457
pi 0.776 0.804 0.817 0.848 0.870 0.897 0.952
SENS vi 0.780 0.808 0.820 0.853 0.875 0.902 0.961
LR 0.742 0.791 0.809 0.848 0.874 0.902 0.955
WILC 0.704 0.761 0.780 0.825 0.855 0.886 0.947
pi 0.999 0.998 0.995 0.981 0.955 0.891 0.538
SPEC vi 0.999 0.997 0.995 0.980 0.953 0.888 0.529
LR 0.999 0.996 0.992 0.972 0.938 0.862 0.516
WILC 1.000 0.998 0.996 0.983 0.958 0.895 0.563
pi 0.003 0.012 0.023 0.058 0.087 0.105 0.089
RISK vi 0.003 0.012 0.022 0.058 0.086 0.102 0.081
LR 0.003 0.014 0.026 0.065 0.094 0.110 0.089
WILC 0.003 0.014 0.025 0.064 0.093 0.111 0.091
Table 3.4: Error rates for the simulation study with respect to the proportion of differ-
entially expressed genes p. Data were simulated with m = 10. A level of FDR control of
δ = 5% was used.
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with p, whereas specificity decreases, especially when p is very large.
3.4.4 Influence of m
A very interesting aspect of the methodology proposed is its validity for any value of m.
As we mentioned previously, no asymptotic assumptions are required for Theorems 3.1
and for 3.2. It is then very interesting to compare the performance of our method with
respect to the others when m is small. In this section, data were generated with p = 0.1
and the FDR was controlled at a level of 5%. Values of m were taken to be m = (4, 10, 20).
Results are presented in Table 3.5.
We can see that the two Bayesian methods are not affected by the values of m, as far as
the control of the FDR is concerned. However, both performances increase with respect
to the other rates when m increases, and we can say that the two methods are equally
affected by the increase or decrease ofm. As expected, the two methods using p-values are
the most affected by the value of m. First, when m is very small (m = 4), the Wilcoxon
test is not able to detect any gene. Furthermore, as we could expect, the performance
of the likelihood ratio test increases significantly with m, since p-values of this test are
based on the asymptotic properties of the likelihood ratio statistic. As an illustration, we
show in Figure 3.2 the histograms, under the null hypothesis, of the p-values based on the
likelihood ratio statistic, as well as the histogram of the probability pi, for a very small
value m = 4. Both probabilities are assumed to be uniform under the null hypothesis,
and the multiple testing procedure used is based on this assumption. We can clearly see
that our approach, as we showed in Theorems 3.1 and 3.2, is not affected by the small
value of m, whereas the p-value from the LR test is clearly not uniform. Again, this is
an important advantage of the method we propose over the frequentist methods using
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Error Rate Method m = 4 m = 10 m = 20
pi 0.046 0.050 0.051
FDR vi 0.051 0.055 0.055
LR 0.113 0.078 0.065
WILC – 0.044 0.048
pi 0.030 0.020 0.014
FNR vi 0.030 0.019 0.014
LR 0.037 0.020 0.014
WILC – 0.023 0.015
pi 0.698 0.821 0.871
SENS vi 0.705 0.825 0.873
LR 0.631 0.813 0.870
WILC – 0.785 0.858
pi 0.974 0.995 0.993
SPEC vi 0.974 0.995 0.992
LR 0.969 0.992 0.991
WILC – 0.996 0.993
pi 0.032 0.022 0.017
RISK vi 0.031 0.022 0.018
LR 0.043 0.026 0.019
WILC – 0.025 0.018
Table 3.5: Error rates for the simulation study with respect to the number of observations
available for each gene, m. Data were simulated with p = 0.1. A level of FDR control of
δ = 5% was used.
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Figure 3.2: Histograms of the p-values from the likelihood ratio test (left) and of the pi’s
(right) under H0: Simulated data, m = 4.
p-values.
3.4.5 Influence of the estimated proportion of differentially ex-
pressed genes, p̂
In this last section, we finally study the influence of the estimated proportion of differen-
tially expressed genes, p̂. As we mentioned before, regarding the two Bayesian methods
(pi and vi), this proportion is estimated using an empirical Bayes approach, maximizing
the predictive distribution of the data. The same value of p̂ was taken for the Wilcoxon
approach (in the multiple testing procedure) since this method is obviously not model-
dependent. Finally, for the likelihood ratio test, the estimation of p by maximum likeli-
hood leading to an over-parametrization of the model, we chose to use the real value of
p.
If the model is correctly specified (which is the case in this simulation study), values of p
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Error Rate Method p̂ = 0.01 p̂ = 0.05 p̂ = 0.1 p̂ = 0.3 p̂ = 0.5 p̂ = 0.7 p̂ = 0.9
FDR pi 0.046 0.047 0.050 0.065 0.090 0.148 0.443
vi 0.016 0.037 0.054 0.102 0.152 0.224 0.400
FNR pi 0.020 0.020 0.020 0.020 0.019 0.017 0.014
vi 0.023 0.021 0.020 0.018 0.017 0.016 0.014
SENS pi 0.815 0.815 0.816 0.822 0.830 0.843 0.885
vi 0.793 0.812 0.820 0.836 0.847 0.859 0.884
SPEC pi 0.996 0.995 0.995 0.994 0.991 0.983 0.920
vi 0.999 0.996 0.995 0.989 0.983 0.972 0.935
RISK pi 0.023 0.023 0.023 0.024 0.025 0.031 0.083
vi 0.022 0.022 0.023 0.026 0.030 0.039 0.071
Table 3.6: Robustness of the pi and the vi method to the estimation of the parameter p.
Data were simulated with m = 10 and p = 0.1. A level of FDR control of δ = 5% was
used.
are usually correctly estimated. However, when p is very small and when n is very large,
maximum likelihood methods or empirical Bayes methods may not provide accurate es-
timates. Storey (2002) proposed a method to estimate the parameter p, as we mentioned
in (2.3), but again, accurate estimates are difficult to obtain. For these reasons, it is of
interest to study the behavior of the methods when the parameter p is not well estimated.
In this section, data were simulated with m = 10 and the FDR was controlled at a level of
5%. A proportion p = 10% of the genes were generated under the alternative hypothesis.
The parameter estimate p̂ was artificially taken to be p̂ = (0.01, 0.05, 0.1, 0.3, 0.5, 0.8, 0.9).
Since this parameter is used exactly in the same way for the pi , the WILC and the LR
method, only the results regarding the pi method are presented here. These results can
be compared with those obtained by the vi method. Note that this method requires the
value of p̂ to compute the probabilities vi, which is not the case for the pi. As we can
see in Table 3.6, the vi method is the least robust to the lack of knowledge of the true
value of p. Of course, both methods are influenced by the value of p̂, but we can see
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for instance that with the vi method, the FDR goes further away to the level of control,
δ = 5% as p̂ goes away from the true value p = 0.1. The FNR is also more stable using
the pi method, as well as the RISK. Regarding the sensitivity and the specificity, both
methods seem to be influenced the same way by an over or under estimation of p.
3.4.6 Summary and discussion
We presented in this chapter a particularly favorable case of the half-space approach de-
scribed in Chapter 2. Through the proof of two theorems, we showed that the results
presented in Chapter 2 regarding the posterior probability of half-space hold in a non-
asymptotic manner under a non-informative gamma model, or under a conjugate gamma
model. Note that this has been proven under some conditions that are easily satisfied
in microarray experiments. Using four different microarray datasets, we could illustrate
the fact that the gamma conjugate model may be a good candidate to describe this type
of data. Using an extensive simulation study, we also illustrated several properties and
advantages of our proposed approach (using the posterior probability of the one-sided
alternative hypothesis), over other approaches using traditional p-values, parametric or
non-parametric. We could also compare our method with the one proposed by Muller
et al. (2004), that uses the two-sided version of the posterior probability pi.
In general, we have seen that the two Bayesian approaches perform better than the fre-
quentist ones in terms of the error rates FDR, FNR, SENS, SPEC and RISK. In terms
of the control of the FDR, these Bayesian methods have the main advantage of being
insensitive to small values of m, whereas the Wilcoxon test or the likelihood ratio tests
are especially inefficient in this particular situation, typical of microarray experiments.
Comparing the two Bayesian approaches with respect to each other, we note several ad-
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vantages of our approach: it is able to provide a strict control of the FDR below the
specified level without a loss in terms of the False Negative Rate, it is significantly less
influenced by a poor estimation of p, which is a great advantage since this quantity can
be hard to estimate accurately in practice, and finally, it performs better when p is small,
which is typically the case in microarray experiments.
Working with the posterior probabilities defined here provides some great advantages.
First, they can be used as p-values in a situation where p-values cannot be computed
accurately. In microarray experiments, the number of replications, and hence the number
of data points available for each gene, is not large enough to make inference on each gene
in a frequentist setting. Bayesian hierarchical models, in the other hand, can provide
a gene-specific inference keeping the number of parameters estimated reasonably small.
The second advantage of the posterior probability used here is that it does not require
the computation of a likelihood, or a marginal distribution. This allows us to work also
with non-informative models, that may have improper priors, and consequently improper
marginals. Some popular Bayesian hypothesis testing techniques require the use of the
odds ratio of the marginals under the null and alternative hypothesis, as we have seen
with the approach proposed by Muller et al. (2004). In such cases, the statistic of the
test directly depends on the value of p, the proportion of alternative hypotheses in the
dataset. This makes these types of methods less robust to a misspecification of this
parameter. Furthermore, these methods are unfortunately unable to deal with non in-
formative models, that have been proven to be very useful. Finally, we note that our
approach allows us to differentiate between over expressed genes and under expressed
genes, or allow us to test one-sided hypotheses, which is not the case of what we have
called the vi method. Looking at the direction of the fold change in the data, once a gene
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is detected as differentially expressed might be misleading: this is especially the case of
genes for which a very strong array or dye effect is present.
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Chapter 4
A multiplicative random effect
ANOVA model for microarray data
In the previous two chapters, we have developed a multiple testing strategy, in a Bayesian
framework, that can be used through the computation of the posterior probability of
the one-sided alternative hypotheses. In such procedures, the design structure of the
microarray experiment is not taken into account and there is the possibility of a potential
confounding between the effect of the treatment and some sources of variation due to the
arrays, the dyes or some genes themselves. It is clear that, to the extent these sources of
variations are understood, they should be incorporated in the model. Kerr & Churchill
(2001a), Kerr et al. (2001b) and Kerr et al. (2002) studied in a series of three papers
the potential sources of variation in a microarray experiment. They were the first to
incorporate the potential sources into an ANOVA model for gene expression data. Such
a model enables the normalization of the data from array to array, but can also be used to
detect differentially expressed genes through the estimation of the effect of the treatment
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for each genes.
In the first section of this chapter, we review the ANOVA model developed by Kerr &
Churchill (2001a) as well as its extension to the case where some effects are treated as
random. In the second section, we present a new multiplicative ANOVA model, that
will be shown to be a generalization of the gamma hierarchical model introduced in the
third chapter. Furthermore, we see that the posterior probabilities introduced in the
third chapter can be estimated using a Gibbs sampling strategy. Under some specific
constraints on the covariates of the ANOVA model, we also show that the distribution
of these posterior probabilities of differential expression can be approximated under the
null hypothesis by a uniform distribution. This result is similar to the one presented in
Chapter 3. Finally, the different ANOVA models presented are applied to the DBLFLIP
dataset and to a simulated dataset in the last two sections of this chapter.
4.1 An additive ANOVA model for microarray data
Several factors have been identified so far as contributing significantly to the variability of
the data. Either these factors need to be incorporated in the model describing the data,
or the data need to be normalized to correct for these effects, prior to the analysis. In
both approaches, an ANOVA model seems to be a good choice to control this variability.
Kerr & Churchill (2001a), Kerr et al. (2001b) and Kerr et al. (2002) were among the first
statisticians to really emphasize the importance of a controlled design in a microarray
experiment. In particular, they identified that the variation of the data arises from four
main sources: the arrays (A), the dyes (D), the treatments (T) and the genes (G). Here,
we note that we consider an experiment involving two dyes and K treatments. In ad-
68
dition to the main effects, some interactions contribute to the variation in the data. In
particular, the array-dye interaction effect (AD) reflects the variability of the hybridiza-
tion procedure (that allows the cDNA to bind to the DNA on each spot of the array)
from array to array. Any interaction involving the gene effect is called a gene-specific
effect. The gene-treatment interaction effect (TG) is the effect of interest and allows us
to measure, for each gene, the effect of the treatment. The gene-dye interaction (DG)
effect arises when, for example, the efficiency of incorporation of a dye varies for some
specific genes. Finally, the array-gene interaction effect (AG) is due to the difference, in
terms of amount of cDNA available for hybridization, from one spot (gene) to another,
on each array.
Due to the structure of a microarray experiment, a careful design is necessary to avoid
confounding between the effect of interest and some ancillary effects. To have a better
understanding of the issues brought by such experiments in terms of the design, we first
consider one gene per array. Since the same set of genes is printed on each array, the
generalization to n genes is trivial. As we mentioned in the first chapter, each array is
probed with two differently labeled cDNA samples (treatments). Then, we can infor-
mally say that two dyes and two treatments are applied on each array, for a total of two
measurements per gene. The arrays can then be considered as being experimental blocks
factors of size two. When there are more than two treatments to compare, not every
treatment appears on every array and therefore, the experimental design is referred as
an incomplete block design. Now, let us consider the case of two treatments. If each
treatment is constantly labeled with the same dye, the issue of non-balance with respect
to the dyes is then raised. In this case, the dye and treatment effects are completely
confounded. In order to estimate the effect of the different fluorescent labels and then
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Green Red
Array 1 T1 T2
Array 2 T2 T1









Table 4.2: Confounding structure for the dye-swap experiment
to minimize potential biases, the concept of dye-swapping has been introduced, which
balances the dye and treatment factors. In dye swap experiments, each of the two treat-
ments is labeled with both the red and the green dyes, over two replicated arrays (using
the same mRNA samples). Although this technique is more costly in that it doubles the
total number of arrays used, it is worthwhile since it allows the estimation of the dye
effect in the model as well as a the reduction of the estimated variance of the data,
The design of a dye-swap experiment is presented in Table 4.1. We note that this
design has the structure of a Latin Square and its confounding structure is presented in
Table 4.2.
In the case of more than two treatments, a loop design can be efficient if the number
of treatments is not too large. This design is presented in Table 4.3 and we can see that
similarly to the dye swap, it is balanced with respect to the dyes since each treatment
is labeled twice. This design loses in efficiency (average precision) when the number of
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Green Red
Array 1 T1 T2
Array 2 T2 T3
... ... ...
Array (K-1) TK−1 TK
Array K TK T1
Table 4.3: A loop design involving K treatments T1, . . . , TK.
treatments compared increases, or when one wants to make every pairwise comparison.
Furthermore, this design, like the dye-swap one, is not robust in the sense that the loss
of a single array greatly affects the efficiency. For alternative designs, we refer to Kerr &
Churchill (2001a).
Finally, as we mentioned in the first chapter, replication is a crucial step in microarray
experiments. Genes are usually spotted two or three times on each array, using the same
RNA source (subsampling). But inference about the biological population can only be
made through the use of several arrays, where the mRNA extracted for each array comes
from different biological samples. In practice, the designs described should be replicated
at least two or three times using different biological samples of mRNA, to account for the
biological variability in the model. These replicated experiments are referred as multiple
dye-swap or multiple loop designs.
4.1.1 A fixed effect model
The ANOVA model used in the types of experiments described above is the following:
log(Xijkgr) = µ+ Ai +Dj + (AD)ij +Gg + (TG)jg + (AG)ig + Sr(ig) + εijkgr,
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where Xijkgr is the intensity for array i, dye j, treatment k, gene g and spot r (in the case
where genes are spotted several times on the arrays). In many cases, the intensity X has
been previously transformed using a normalization procedure for each array separately.
The term µ of the model refers to the overall average intensity and the following terms
refers to the variation due to the array, dye, treatment, gene, as well as some specific in-
teraction involving each gene. The term S captures the difference among the duplicated
spots within an array. Finally, the terms ε’s represent the error of the model and the only
random quantity, if we consider all the effects in the model to be fixed. They are assumed
to be independent and identically distributed with mean 0. We note that a normality
assumption on the residuals is not required here. Note that treatment main effect was
omitted on purpose in the model, since it is aliased with the array-dye interaction. This
aliased structure does not have an impact on the analysis, since we are only interested
in treatment differences that are specific to one gene, meaning that we care about the
gene-treatment interaction.

























r Sr(ig) = 0. The effect of interest is the treatment-gene interaction,
(TG)kg, for each gene g and treatment k, with least squares estimate ( ˆTG)kg = t..kg. −
t..k.. − t...g. + t...... Here, t represents the logarithm of the intensity and a ”.” as an in-
dex means to average over that index. Under such a model, detecting the set of genes
differentially expressed under at least one of the K treatments requires the test of the
null hypothesis H0g : (TG)1g = . . . = (TG)Kg = 0 for each gene g. For the case of two
treatments, under the latin square design, this is equivalent to testing the hypothesis
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of no differential expression between two treatments, where the null hypothesis becomes
H0g : (TG)1g = (TG)2g.
Three types of F-test statistics are proposed by Cui (2004), that differ in their denom-
inator. The first statistic (F1) is a gene-specific F-statistic that compares the variation
among replicated samples within and between treatment conditions. Its denominator is
then based on the residual sum of squares of the model. The second statistic (F3) is
identical to F1, but assumes a common error variance for all genes. The third statis-
tic’s denominator (F2) is a weighted combination of global and gene-specific variance
estimates. We note that F2 and F3 do not follow the tabulated F distributions. Further-
more, the assumption of normality of the residuals does not seem to be appropriate (cf
Kerr et al. (2001b)). A bootstrap analysis of the residuals is often required to assess the
significance of the test statistics (see Efron & Tibshirani (1986)).
4.1.2 A mixed ANOVA model
A natural variation of the ANOVA model described earlier is to treat some of the effects
as being random. Cui (2004) propose to treat the effects (AG) and S as being normally
distributed with mean 0. The three types of F-tests can still be computed and we refer
to Littel, Milliken, Stroup & Wolfinger (1996) for more details. Another type of mixed
model was also introduced by Wolfinger, Gibson, Wolfinger, Bennett, Hamadeh, Bushel,
Afshari & Paules (2001). This model is a two-stage model, the first stage being referred
as a normalization model, where
log2(Xijkgr) = µ+ Ai +Dj + Tk + (AT )ik + εijkgr
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The terms Ai, (AT )ik and εijkgr are assumed to be normally distributed with mean 0.
The second stage of the model is referred to as a gene model, where the residuals of the
first model rijkgr are fitted such that
rijkgr = Gg + (TG)kg + (AG)ig + γijkgr
Here, the terms (AG)ig and γijkgr are also assumed to be normally distributed with mean
0. All the random effects of the two-stage model are assumed to be independent both
across their indices and with each other. Furthermore, the variance of the effects (AG)ig
and γijkgr is different across the genes, accounting for heterogeneity between the genes.
4.2 A multiplicative random effects ANOVA model
Traditionally, microarray data (and in general, design of experiment data) are analyzed
using an additive regression model, either applied on the raw data, or on a suitable trans-
formation of the data. In the case of microarray data, models are traditionally applied
on the logarithm, in base 2 of the raw intensities. As we mentioned in the introduction of
this chapter, our goal is to extend the multiple testing procedure developed in Chapter 2
and 3, in order to include important factors in microarray experiments, such as arrays and
dyes. In order to do so, the model must satisfy the following criteria: the intensities are
assumed to be gamma distributed, and the gene-specific effects considered are randomly
distributed according to an inverse gamma distribution (to match the conjugate gamma
model used before). Many computational challenges arise with this type of model, mostly
due to the fact that the gamma distribution is not as tractable as the normal distribution,
for instance. A solution to these computational issues is to keep the data on its natural
74
scale, and to consider the model as being multiplicative, instead of additive. Using such
a framework, the random effect model can be accurately defined, and effects can be es-
timated using a Gibbs sampling approach. Note that the multiplicative model described
in the following subsection is not equivalent to a log-linear model, using the log-gamma
distribution.
4.2.1 Definition of the model
The factors we consider in the model are the same as the factors presented in the last
section: Array, Dye and Treatment. We first assume that the data have been previously
corrected such that no global Array, Dye or Treatment effects are present. A simple,
efficient and easy way to do so is, as we did in Section 3.3, to normalize the data such
that the mean is the same across the arrays, dyes and treatments. For instance, we may
assume the following model:
log(Xijkgr) = µ+ Ai +Dj + Tk + εijkgr,
where µ represents the global mean, Ai is the ith array effect, Dj is the jth Dye effect
and Tk is the kth treatment effect. Note that we consider an experiment with I arrays
(i = 1, . . . , I), 2 dyes (j = 1, 2), K treatments (k = 1, . . . , K), n genes (g = 1, . . . , n) and
m technical replications on the same array (r = 1, . . . , m). The error term is noted εijkgr
and is assumed to have a mean of zero. The least square estimates for such a model can
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be easily obtained, and we find
µ̂ = X̄,
Âi = X̄Ai − X̄,
D̂j = X̄Dj − X̄,
T̂k = X̄Tk − X̄,
where X̄ is the global average of the data, X̄Ai is the average for the ith array, X̄Dj is the
average for the jth dye and X̄Tk represents the average over the kth treatment. Under
such a simple model, data can be normalized so that
(log(Xijkgr))
New = log(Xijkgr) − Âi − D̂j − T̂k.
Of course, this model is over-simple, but has the advantage of pre-processing the data
in a very efficient way, for further gene-specific analysis. Note that in the following, the
notation X will be used instead of XNew and then, data are assumed to be pre-processed.
The model we propose is a gene-specific model, where all the effects are multiplicative,
and where the data remain in their original scale. For instance, we assume that
E [Xijkgr|(AG)ig, (TG)kg, (DG)jg] = (AG)ig × (TG)kg × (DG)jg,
where (AG), (TG) and (DG) are the gene-specific Array, Treatment and Dye effects. In
other words, we assume here that the gene-specific effects are additive for log(E[Xijkgr]),
instead of assuming additivity for E[log(Xijkgr)] in the usual additive models. In order
to allow more flexibility, and in order to minimize the impact of the small number of
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observations available for each gene, all the effects are assumed to be random, making
the model a multiplicative random effects ANOVA model. The distributional assumptions
are a generalization of the model described in the previous chapter, and we have




(AG)ig × (DG)jg × (TG)kg
)
,
1/(AG)ig ∼ Gamma(a(A)i , b(A)i ),
1/(DG)jg ∼ Gamma(a(D)j , b(D)j ), (4.1)
1/(TG)kg ∼ Gamma(a(T )k , b
(T )
k ),
Note that this choice of distribution allows us to work with a conjugate framework, and
seems to be the only choice leading to a computation of posterior distributions that are
mathematically tractable. The scale of the data is specified for each gene, dye, array and
treatment. The shape is assumed to be constant across the genes, but specific to each
array/dye (i, j) combination. We note that, due to the design of microarray experiments,
assuming the shape to be different for each array i and dye j is equivalent to assuming a
specific shape for array i, dye j and treatment k. Then, writing the terms γ’s as γij or
γijk is equivalent.
When we define an ANOVA model, we need to impose some constraints in order to provide
an adequate estimation of the effects of interest (in this case, the gene-specific effects).
In additive models, the choice of the type of constraints determines the estimation of
the effects, but does not have a real impact on the model itself. In our case, this step is
particularly important, since it has a direct influence on the tractability of the calculations
leading to the estimation of the posterior distributions of the gene-specific effects. For

















k(TG)kg = 0 are used. In our
context, this type of constraints (adapted to the multiplicative setting) cannot be used,
for computational reasons that would prevent us from finding the posterior distribution
of the gene-specific effects. As a results, the following constraints are used, for each
g = 1, . . . , n:
(AG)Ig = 1, (4.2)
(DG)2g = 1.
We note here that no constraints were imposed on the gene-treatment effects (TG)kg.
The choice of constraints (4.2) has some consequences on the interpretation of the effects
of interest. For example, the effect of array i is computed with respect to the effect of the
last array I, for each i = 1, . . . , I − 1. In other words, testing the hypothesis (AG)ig = 1
(no effect of array i in gene g) is equivalent to testing the hypothesis (AG)ig = (AG)Ig.
A similar interpretation holds for the gene-dye effects. However, since no constraints
were imposed on the treatment effects, the hypothesis (TG)kg = (TG)k′g really tests the
hypothesis of no difference in expression between treatments k and k′, for the gene g,
which is the focus of our analysis.
The constraints defined lead to the definition of the covariates of the model. Each covari-
ate is denoted by zij (noting that zij is equivalent to zijk) and is an indicator variable. For
the gene-array effects, (I − 1) covariates, z(A1), ..., z(AI−1), are defined such that z(Ai) = 1
if the observation corresponds to array i, and 0 otherwise. Similarly, we define a single
covariate, z(D), for the dye effect. Regarding the treatment effects, K indicator variables
(one for each treatment) are defined and are noted z(T1), . . . , z(TK). From now on, for
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better readability, the set of (I − 1) + 1 + K covariates corresponding to the array, dye
and treatment effects is denoted z(1), . . . , z(p). The model, defined in (4.1), can then be
written as















1/θtg ∼ Gamma (at, bt) , for t = 1, . . . , p,
where the parameters (θ1g, . . . , θpg) are the random coefficients arising from the mul-
tiplicative structure of the model. Furthermore, the observations are assumed to be
independent, conditionally on θ. The variables θ are also assumed to be independent.
4.2.2 Inference about the parameters via Gibbs sampling algo-
rithm
The advantage of working with the model defined above is that inference about θtg|xg
e
is possible, for t = 1, . . . , p (xg
e
representing the set of measurements available for gene
g). This allows us to work with the posterior probability pg, defined similarly to the
probability pi in the last chapter, such that
pg = P (θtg > θt′g|xg
e
),
where, for example, θtg and θt′g represent the mean expression for treatment t and t
′
respectively.
We are going to see now that the computation of such statistics can be done via the








1g , . . . , θ
(0)
pg from π(θ1g), . . . , π(θpg).
1.1) Generate θ
(1)











pg from π(θpg|θ(1)1g , . . . , θ(1)(p−1)g, xg
e
)
2.) Repeat steps (1.1)-(1.p) K times to obtain θg
e
(1), . . . , θg
e
(K).
It can be shown that for all t = 1, . . . , p
θ
(k)
tg → θ ∼ π(θtg|xg
e
) in distribution, when k → ∞.
















× #{q : θ(q)tg > θ(q)t′g , q = 1, . . . , k} → P (θtg > θt′g|xg
e
).
In the context of our model, the Gibbs sampling algorithm can be easily applied and
then, numerical computation of E[θtg|xg
e
] and P (θtg > θt′g|xg
e
) is possible for each gene
g = 1, . . . , n and each (t, t′) ∈ {1, . . . , p}. Of course, it requires the knowledge of the
conditional probability density function of π(θtg|θ[−t]g, x∗g
e
), where θ[−t]g represents the set
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) can be decomposed into two expo-
nentials, where the second part does not depend on θtg. In particular, we can write, for




















































































































for t = 1, . . . , p. We can then see that if we condition on all θ’s except one, we retrieve the
gamma conjugate model defined in Chapter 2. Again, note that the computationability
of this problem is a direct consequence of the choice of distribution for the random effects,
as well as the choice of the type of constraints on the effects.
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4.2.3 Estimation of the hyperparameters
Before fitting the model to the data, several hyperparameters need to be estimated. In
total, (2I) γ’s parameters (for the conditional gamma distribution) and 2p parameters
for the inverse-gamma prior (parameters a’s and b’s) are present in the model. Despite
the fact that the conditional posterior distribution of each parameter θtg conditionally on
θ[−t]g can be obtained, the unconditional posterior distribution of θtg cannot be found.
As a result, the marginal distribution of the data xg
e
cannot be obtained and an empirical
Bayes approach maximizing the unconditional likelihood is not possible. We then propose
the following approach: first, naive estimates of the parameters θ’s are obtained using a
traditional least-square method, ignoring their random component. In particular, for the
replicated dye-swap design (with K = 2 treatments) presented in Table 4.1 we get, for
each gene g






























1/I × . . .× (θ̃AI−1, g)1/I × (θ̃Dye, g)1/2
,












where xS, g represents the set of all the observations belonging to the set S, for gene g.
Once these naive estimates are obtained, we can fit the following model:
1/θ̃tg ∼ G(at, bt),
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for each t = 1, . . . , p, in order to obtain estimates of the coefficients at and bt.
Regarding the coefficients γ’s, we first normalize the data for the gene-specific array and
dye effects, using the naive estimates, such that
X∗ijkgr =
Xijkgr
θ̃Array i, g × θ̃Dye, g





1/θTreat k, ∼ G(âTreat k, , b̂Treat k, ),
where âTreat k, and b̂Treat k, are the estimated parameters obtained previously. In this case,
the model is identical to the one fitted in Chapter 3, and estimates of the parameters γ’s
can be obtained by maximizing the predictive density function, as we did before. This
way of estimating the hyperparameters of the model is very naive, and in practice, the
naive parameters θ̃’s tend to be less variable than the real ones. However, as we will see
in our simulation study in Section 4.4, estimates appear to be very accurate if the model
assumed is true.
4.2.4 Normalization of the data and detection of differentially
expressed genes
The model we presented can be used for two different purposes: normalization or detection
of differentially expressed genes. If one wants to normalize the data to correct for the
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where we suppose that the first K θ’s represent the K treatments. We note here that
we divide the raw data by the posterior expectation of the gene-specific effects, except
for the gene-treatment interaction effects. Usually, the first interest of the biologists is to
detect differentially expressed genes under the treatments. Normalizing the data by the
gene-treatment effects would then remove the effect of interest.
By making inference about the parameters θtreat k, g and θtreat k’, g corresponding to the
treatments k and k′, for example, we are able to detect the genes that are differentially
expressed under these two treatments. This can be done by computing the posterior
probabilities pg defined as pg = P (θtreat k, g > θtreat k’, g|xg
e
). If we assume the other gene-
specific effects as being fixed and known, the model (4.1) can be written exactly like
the hierarchical gamma model described in the third chapter, involving data from two



















In this case, the variables X∗ and Y ∗ represent normalized data for treatment k and k′
respectively. We can also denote θkg and θk′g as being θxg and θyg. Then, under the

















1/θyg ∼ Gamma(a, b).
Then, the Theorem 3.2 proven in the third chapter can be generalized, and we obtain the
following theorem.










, Hg = 0
)
,
where ξg is a gamma variable with shape parameter a and rate parameter 1/θyg and where
the variable Hg is defined as the variable Hi in the previous chapter. Furthermore, if the
following conditions are satisfied
i) a is an integer
ii) the βth quantile of m
∑
i X̄igγxi + ξg under H0g, given m
∑
i Ȳigγyi is large enough,
for β > 0.5
then, pg is approximately uniformly distributed under H0g on the interval [0, 1].
The proof of this theorem is very similar to the proof derived for Theorem 3.2. Fur-
thermore, since this theorem can be proven conditionally on all the gene-specific effects,
by integrating over the distribution of these effects, the theorem is still valid uncondi-
tionally. As a result, we can use the posterior probability pg as a p-value, for detecting
differentially expressed genes, and controlling the FDR at the same time.
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Design (Dye,Array,Treat) 2,1,1 1,1,1 2,2,1 1,2,1 1,3,2 2,3,2 1,3,2 2,4,2
Estimated γ 98.00 58.54 62.70 87.21 91.73 60.69 66.69 73.33
Table 4.4: Estimated parameters γ’s for the DBLFLIP dataset
Parameters a aDye aArray1 aArray2 aArray3 aTreat
Value 63.78 1.88 4.91 3.30 0.94
Parameters b bDye bArray1 bArray2 bArray3 bTreat
Value 63.28 1.41 4.42 2.81 230.63
Expected value of Dye Array 1 Array 2 Array 3 Treatment
the effects: b/(a− 1) 1.007 1.60 1.13 1.22 Not defined
Table 4.5: Estimated parameters a’s and b’s for the DBLFLIP dataset. Note that assump-
tions of Theorem 4.1 require the parameters (a, b) to be the same for both treatments.
4.3 Application: Study of the DBLFLIP dataset
In this section, we present the results of the multiplicative ANOVA model proposed, when
applied to the DBLFLIP dataset, first described in Section 3.3. Three other datasets will
be studied in details in Chapter 6. We recall that this experiment is constituted of four
arrays (I = 4), two dyes and two treatments (K = 2). The estimated coefficients
(a, b)’s and γ are presented in Tables 4.4 and 4.5. It is hard to compare these values with
those obtained in the same dataset with gamma model developed in the last chapter (see
Table 3.2), since the expected value of the gene expression is now decomposed into three
different effects. However, as a reference, we note that we obtained γ = 9.79, a = 1.138
and b = 795.29. Furthermore, the expected value of the effects is also given in Table 4.5.
We can see that even if the data were pre-corrected for the global effects, a strong gene
interaction remains present regarding the first array.
In order to compute the posterior expectations of the gene-specific effects as well as the
posterior probabilities pg, the Gibbs sampling algorithm was applied, as described in
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Figure 4.1: DBLFLIP dataset: convergence rate of the Gibbs sampling posterior expec-
tations for the first gene
Section 4.2.2. The number of iterations used was 2500 (for each gene), where the first
500 iterations were ignored in the computation of the estimates. Different starting values
were tried, generated form the prior distribution of the effects, or arbitrary fixed. In all
the cases, values of the six estimates were exactly identical after the first 500 iterations
(ignored in the computation).
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Quantile Dye Array 1 Array 2 Array 3 Treatment 1 Treatment 2
0% 0.677 0.013 0.100 0.090 42.455 41.561
10% 0.889 0.429 0.605 0.513 103.014 102.690
20% 0.924 0.622 0.739 0.670 156.803 157.411
30% 0.949 0.788 0.834 0.803 218.767 218.811
40% 0.971 0.946 0.917 0.918 297.453 297.634
50% 0.992 1.103 1.006 1.039 401.925 404.052
60% 1.014 1.272 1.108 1.176 558.812 558.391
70% 1.042 1.444 1.233 1.336 823.850 819.416
80% 1.078 1.671 1.399 1.551 1298.590 1282.088
90% 1.142 2.027 1.668 1.888 2468.606 2465.324
100% 2.052 62.977 65.432 78.722 45857.500 47673.000
Table 4.6: Quantiles of the posterior expectations of the gene-specific effects for the
DBLFLIP dataset
An illustration of the convergence rate of the posterior expectations, for the first gene
of the dataset is presented in Figure 4.1. The posterior expectations of the gene-specific
effects are presented in Table 4.6. Note that in this dataset, a very strong array effect is
present. This is true especially for the first array, whose expression average was half that
of the other arrays, before the correction of the data. This dataset illustrates perfectly a
situation where ANOVA models are very useful and where there is the need to correct for
these effects. The remaining analysis of this dataset is going to be divided into two parts:
a goodness of fit study, where we compare the fit provided to the data under different
conditions, and a study of the set of genes detected, including a comparison with the
mixed model developed by Wu, Kerr, Cui & Churchill (2003) and implemented in the
software package MAANOVA.
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4.3.1 Goodness of fit study
Goodness of fit can be evaluated by looking at the residuals from the model we assumed.

























The first question of interest is to know if fitting a multiplicative model (including all the
gene-specific effects) is efficient, compared to the model defined in the previous chapter,
where only the treatment-gene specific effects were considered.
Figure 4.2 presents the boxplots of the logarithm of the residuals (for the two treatments)
when we fit a model with only the treatments effects, and when we fit a multiplicative
model including all the array and dye effects. Note that in both cases, data have been
corrected for the main Array, Dye and Treatment effects. We can see that there is a
very strong improvement in the residuals by considering the multiplicative model. Not
only their mean is closer to 1, but the variability is considerably reduced, illustrating the
advantage of considering a more complex model.
Using these residuals, we can also construct some diagnostic plots, such as some quantile-
quantile plots. By using the posterior expectation of the effects as the estimated coeffi-
cients of the regression model, and following model (4.1), we should have approximatively





















Treatment 2 (log scale)
Figure 4.2: Box-plots of the residuals for the multiplicative model (on the right), and for
the model considering only the treatment-gene effects (on the left)
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Figure 4.3: Quantile-quantile plots for the DBLFLIP dataset, using the multiplicative
model
for each set (i, j). We can then plot the observed quantiles of the residuals versus the
quantiles of a gamma distribution.
Such a qq-plot, for the multiplicative model, is presented in Figure 4.3, for the 8 combi-
nations of Dye/Array/treatment. We can see that the fit provide by the model to this
dataset is very good, with almost straight lines for each set of residuals.
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4.3.2 Testing for differentially expressed genes
We applied the methodology proposed, using the posterior probabilities pi, to this dataset.
At a FDR control level of 5%, 287 genes were detected, which represents 1.96% of the genes
printed in this experiment. The mixed model presented in Section 4.1.2 was also fitted,
using the R package MAANOVA. In this model, the logarithm of the data is assumed
to be distributed according to a normal distribution, and the gene-array interactions are
the only random effects of the model. In that sense, note that the difference between our
approach and this model is not only in the type of distribution chosen for the data since we
assume all the gene-specific effects to be randomly distributed. FDR-corrected permuted
p-values were computed, from four different F-tests, introduced briefly in Section 4.1.1.
Figure 4.4 presents the normal qq-plots of the residuals obtained. We can see that the fit
provided by the mixed normal model is very poor, and residuals do not follow a normal
distribution. As a result, none of the four F-tests are able to detect any genes, at a
FDR-control level of 5% (the smallest FDR-corrected p-value being around 6%). Note
that even if the truth regarding the state of expression of the genes is unknown, at least
one gene, clearly over expressed in this dataset, should be detected by any method. In
conclusion, this dataset illustrates very well a situation where log-normal models are not
appropriate and where other distributions need to be considered.
4.4 Study of a simulated dataset
We study in this section the application of the multiplicative model described above to a
single simulated dataset. The main purpose of this study is to evaluate the performance
92










































































































































Figure 4.4: Quantile-quantile plots for the DBLFLIP dataset, using MAANOVA
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Parameters Dye Array 1 Array 2 Array 3 Treatment
Real parameters a 63.78 1.88 4.91 3.30 0.94
Estimated parameters 52.28 1.87 4.72 3.22 0.93
Real parameters b 63.28 1.41 4.42 2.81 230.63
Estimated parameters 51.64 1.40 4.24 2.75 228.91
Table 4.7: Real and estimated hyperparameters a’s and b’s
Design (Dye,Array,Treat) 2,1,1 1,1,1 2,2,1 1,2,1 1,3,2 2,3,2 1,3,2 2,4,2
Real γ 98.00 58.54 62.70 87.21 91.73 60.69 66.69 73.33
Estimated γ’s 97.97 58.79 61.61 88.21 90.83 60.25 65.80 74.10
Table 4.8: Real and estimated hyperparameters γ’s
of our proposed method, in terms of error rates, when the parameters are estimated using
the naive approach described in Section 4.2.3. It also allows us to confirm the results from
Theorem 4.1 regarding the uniformity of the probabilities pg under the null hypothesis.
Data were simulated according to the multiplicative model described in this chapter. The
parameters chosen correspond to the ones obtained from the DBLFLIP dataset (shown in
the previous section, in Tables 4.4 and 4.5). Note also that data were simulated according
to the same design as the DBLFLIP dataset, with 2 dyes, 2 treatments and 4 arrays. We
simulated n = 15000 genes, from which 5% are differentially expressed. In practice, we
obtained 726 truly differentially expressed genes.
Regarding the first stage model, the true and estimated parameters are presented in
Tables 4.7 and 4.8. We can see that the estimated parameters are very well estimated
for both (a, b)’s and γ’s. The only important difference between the real and estimated
parameters occurs when the parameters (a, b) are estimated for the dye effect. One reason
may be the very small variance of the naive dye effect, since in this dataset, gene-dye
effects are almost absent.
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Figure 4.5: Quantile-quantile plots for the simulated dataset, using the multiplicative
model
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FDR level # detected FDR FNR SENS SPEC RISK
(true = 726)
1% 683 0.033 0.0046 0.909 0.998 0.0059
5% 700 0.051 0.0043 0.914 0.997 0.0065
Table 4.9: Error rates
The quantile-quantile plots of the residuals are presented is Figure 4.5. Of course, as
expected, we observe an almost perfect straight line, which indicates that those types of
plots, using the posterior expectation of the gene-specific effects, are a good indicator of
the goodness of fit.
Applying the Benjamini-Hochberg method, adapted to the posterior probabilities pg, we
can detect the differentially expressed genes. Finally the error rates observed (FDR,
FNR, SENS and SPEC, defined in Section 3.4) are presented in Table 4.9. We can see
that the results obtained are excellent. At a level of FDR control of 5%, the observed
FDR is almost equal to the expected one. At a level of 1%, the observed FDR is greater
than the observed one, but we expect that if several datasets were simulated, the average
observed FDR would be very close to the expected one. The level of FNR and RISK is
also very small, and the sensitivity is particularly high.
Finally, the histogram of the posterior probabilities pg used, under the null hypothesis,
is presented in Figure 4.6. As stated in Theorem 4.1, they are uniformly distributed on
the interval [0, 1].
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Figure 4.6: Histogram of the posterior probabilities pg under the null hypothesis
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4.5 Discussion
We have proposed in this chapter a new way of defining ANOVA models for microarray
data. The first particularity of this approach is its multiplicative setting, which allows us
to work with the data (normalized) on the raw scale, assuming a gamma distribution. In
the traditional ANOVA models for microarray data, if the effects are all assumed to be
fixed, no assumption about the distribution of the residuals is usually made. However,
when one or more of the effects are assumed to be random (mixed models), the normal
distribution is often the most appropriate choice (in an additive setting). Assuming that
the effects of the microarray experiment act in a multiplicative way allows us to use an-
other kind of distribution, and especially the gamma distribution, which has proven to be
very efficient in modeling gene expression data. Furthermore, the study of the DBLFLIP
dataset illustrated the fact that gamma models may be more appropriate than log-normal
ones in some situations.
In the usual ANOVA mixed models for microarray experiments, the Array/Gene in-
teractions are considered to be random. The model we propose considers all the gene
interactions to be random. We actually showed that it is possible to construct a Bayesian
conditional conjugate model to describe the behavior of the data, for each gene individ-
ually, in function of the effects of interest. This model can be seen as a generalization
of the conjugate model presented in the second chapter, and the theorems presented in
the third chapter can be generalized as well. We can then test for differentially expressed




Probability of half space using
inverse Gaussian models
As we mentioned previously, the use of hierarchical Bayesian models, in the analysis of
gene expression data, has proven their effectiveness, especially when one wants to make
inference on a given gene. Up to now, the gamma/gamma and normal/normal conjugate
models have been used successfully in the literature (cf Newton et al. (2001), Kendziorski
et al. (2002), Newton et al. (2003), Smyth (2004) and Ibrahim et al. (2002)). We show
here how the inverse Gaussian distribution can provide a good alternative to these models,
and how the multiple testing framework developed in Chapter 2 (Theorem 2.2) can be
applied successfully.
In the first section of this chapter, we develop three types of hierarchical inverse Gaussian
models: a conjugate model, a non-informative model and a non-conjugate model. A
goodness of fit study on four real microarray datasets is performed in the second section,
as well as a simulation study of the robustness of these models to the true distribution of
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the data. The multiple testing procedure using the posterior probability of half-space is
finally applied in Section 3, and error rates are compared between the inverse Gaussian
and the gamma models.
5.1 Hierarchical models involving the inverse Gaus-
sian distribution
The inverse Gaussian distribution has been used in many different areas of statistics and
has proven its usefulness as a model to describe positively skewed data. However, most
of the applications are based on the idea of a first passage time for an underlying process
(see Chhikara (1986) for a standard source regarding the inverse Gaussian distribution).
Because it tends to fit ratios of positive random variables well, a natural extension of the
applications of this distribution would be to use it as a way to describe gene expression
data. We believe that the wide variety of shapes generated by its probability density
function makes it a good competitor to the gamma or log-normal distributions that are
typically used with such data. In this section, we propose three models involving the
inverse Gaussian distribution. The first one has the computational advantage of being a
conjugate model, but we will see that it is actually quite restrictive with respect to the




. The second model is
non-informative and does not require the estimation of any hyper-parameters. Finally,
the last model, first proposed by Betro and Rotondi (1991), is expected to provide a good
fit to the data, but is numerically more complex than the other two.
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5.1.1 The inverse Gaussian distribution : an overview
Let X be an inverse Gaussian random variable with parameters µ and λ, denoted by











, x > 0,
where µ and λ are both positive parameters. This density, which is seen to be a member of
the exponential family, is unimodal and positively skewed. The parameter µ corresponds
to the mean of the distribution and λ is a scale parameter. The shape of this distribution
depends on both µ and λ and can conveniently be indexed by φ = λ/µ.

















Figure 5.1: Inverse Gaussian densities for five values of (µ, λ)
shapes and allows the representation of a wide class of unimodal distributions. It can be
shown that when φ→ 0, the distribution is highly skewed, whereas high values of φ lead
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to a more symmetrical distribution.
The moments of the distribution can be found using the characteristic function, and the
mean and the variance are respectively µ and µ3/λ.
The inverse Gaussian distribution has also many convenient properties for the associated
sampling distributions and some are quite similar to those of the normal distribution. One
useful property of the normal distribution is shared only partially: a linear combination of
inverse Gaussian random variables is not inverse Gaussian, unless some specific conditions
on the parameters are satisfied.
Proposition 5.1. Let X1, ..., Xn be independent inverse Gaussian random variables with
parameters (µi, λi), for i = 1, . . . , n and let us consider the random variable X =
∑n
i=0 ciXi. If λi/(µ
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Therefore, if X1, . . . , Xn is a random sample such that Xi ∼ IG(µ, λ) for i = 1, . . . , n,
the sample mean X̄ has also an inverse Gaussian distribution with parameters µ and nλ.
5.1.2 The natural conjugate model
The type of parametrization has a significant impact on the choice of the prior when the
inverse Gaussian distribution is used under a Bayesian framework. With the parametriza-
tion (µ, λ) seen in Section 5.1.1, a natural conjugate prior does not exist, unless µ is known
and λ is unknown (Palmer 1973). However, the parametrization (1/µ, λ) provides a nat-
ural conjugate model that is mathematically tractable.
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Consider the following hierarchical framework, under the same mixture defined in Chap-
ter 2, where the new parametrization implies E[Xij] = 1/θxi and E[Yij] = 1/θyi: Under
the alternative hypothesis H1i, which occurs with probability p

















































Under the null hypothesis H0i, which occurs with probability (1 − p),





























for i = 1, . . . , n and j = 1, . . . , m. N0 denotes the normal distribution truncated at 0
and G∗ denotes the modified gamma distribution. We use the notation Y ∼ G∗(a, b, c)








yb−1e−ay , y > 0,
where φ(.) stands for the standard normal distribution function , Γ(.) is the gamma
function, Fk(.) is the distribution function of a Student random variable with k degrees
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of freedom, and the parameters a, b and c are positive.
This model being conjugate, the posterior and prior distributions have the same form.
We can show that
θxi|xi
e


























, H0i ∼ T0
(




(r′ − 1)β ′i
)
,
where T0(a, b, c2) represents a Student distribution truncated at 0, with a degrees of
freedom, location parameter b and scale parameter c2. In other words, if Z ∼ T0(a, b, c2),
the variable (Z−b)/c follows a Student distribution with a degrees of freedom, truncated
at −b/c. The parameters of the posterior distribution under the alternative hypothesis
H1i are












































yi are defined in a similar way. Finally, the
parameters of the posterior distribution under the alternative hypothesis H1i are:
r′ = 2m+ r,
β ′i =




















In order to compute the odds of differential expression for each gene, we need to compute
















































for i = 1, . . . , n. The function m1(yi
e






































5.1.3 The non-informative model
As we have introduced in Section 5.1.1, when no prior information on the data is avail-
able, one may use a non-informative prior. A popular choice of non-informative prior is
the Jeffreys’ prior, based on the Fisher information matrix. As is often the case, with the
inverse Gaussian distribution, the posterior distribution induced by Jeffreys’ prior is not
a proper distribution. By adapting the model developed by Banerjee & Bhattacharyya
(1979), using the locally uniform reference prior, to the context of a mixture of models,
we obtain:
Under H1i, which occurs with probability p,




π(θxi, λxi) ∝ λ−1xi .




π(θyi, λyi) ∝ λ−1yi .
Under H0i, which occurs with probability (1 − p),








π(θi, λi) ∝ λ−1i .
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This type of prior is commonly used in Bayesian analysis for location-scale parameters.
Although this prior is improper, it leads to the following proper posterior densities:
θxi|xi
e
























, H0i ∼ T0
(



























We note that these posteriors have the same form as the natural conjugate model and are
identical to the extreme case r → 0, which corresponds to the case of an infinite variance
of the gene expression under both treatments. Finally, although the use of an improper
prior distribution on the parameter yields a proper posterior distribution, the marginal
densities remain improper and cannot be computed.
5.1.4 Another hierarchical model involving the inverse Gaus-
sian distribution
As we have seen earlier, the main disadvantage of the natural conjugate model is that
it uses a symmetric distribution for the reciprocal of the mean of highly skewed data.
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Betro & Rotondi (1991) introduced a model that does not impose such a constraint: the
prior for the mean is taken to be inverse Gaussian as well, which brings more flexibility
to the model. Note that this model uses the parametrization (µ, φ), where φ = µ/λ is
the shape parameter of the inverse Gaussian distribution. This allows the hierarchy of
the model to focus directly on the scale and the shape parameter separately. In terms of


















, x > 0.
Consider the following model under the alternative H1i (with probability p):
Xij|θxi, φxi ∼ IG(θxi, φxi),
θxi|φxi ∼ IG(ηx, wxφxi),
φxi ∼ G(ax, bx).
Yij|θyi, φyi ∼ IG(θyi, φyi),
θyi|φyi ∼ IG(ηy, wyφyi), (5.9)
φyi ∼ G(ay, by).
Under the null hypothesis H0i (with probability (1 − p)), we consider
Xij|θi, φi ∼ IG(θi, φi),
Yij|θi, φi ∼ IG(θi, φi), (5.10)
θi|φi ∼ IG(η, wφi),
φi ∼ G(a, b).





ically more complex. However, it is possible to find an expression for the posterior
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[v1iθ2i − 2v2iθi + v3i](m+a+1/2)
I−1i , (5.13)
where
v1xi = mx̄ri + wxη
−1
x ,
v2xi = m+ wx − bx,
v3xi = mx̄i + wxηx,
v1i = mx̄ri +mȳri + wη
−1,
v2i = 2m+ w − b,





















(v1it2 − 2v2it+ v3i)(m+a+1/2)
dt. (5.15)
The parameters v1yi, v2yi, v3yi, Iyi are defined similarly as those for xi
e
. Betro & Rotondi
(1991) showed that the integrals Ixi, Iyi and Ii always exist since ax, ay and a are all
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positive.
If we make the assumption that ax, ay and a are integers, the integral Ixi can be computed
using a double recursion by writing Ixi = Ixi(Ax, Bx), where Ax = m+ax−1, Bx = m+2ax





(v1t2 − 2v2t + v3)(B+1)/2
dt,





(B − 2A+ 1)






The integral I(A,B) can be computed for any integers A > 2 and any integers B > 0 if






















d(B − 1) I(0, B − 2),
where d = v1v3 − v22 .
110
















































The integrals Iyi and Ii will be computed in a similar way. We will see in the last section
of this chapter that the assumption that ax, ay and a are integers is not very strong and
in practice, it does not affect significantly the results.









































) is computed in the same way as m1(xi
e
).
As we have seen, this model seems to be much more flexible than the conjugate one.
Even if it is mathematically more complex, by assuming ax, ay and a are integers, we are
able to find simple expressions for the posterior distributions. Furthermore, we note that
in practice, assuming a integer does not seem to have any important impact on the fit
this model provides to the data, or on the list of genes that are detected as differentially
expressed.
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5.1.5 Estimation of the hyper-parameters and tests for differ-
entially expressed genes
So far, three hierarchical models involving the inverse Gaussian distribution have been
proposed. For the first and last models, the last level of the hierarchy involves some
hyperparameters that need to be estimated. The second model, being non-informative,
does not involve any hyperparameters. For the natural conjugate model, the hyper-
parameters are (p, rx, αx, βx, ry, αy, βy, r, α, β). In the case of the non-conjugate model,
they are (p, ηx, wx, ax, bx, ηy, wy, ay, by, η, w, a, b). As we did for the gamma model in
Chapter 3, these hyperparameters can be estimated using an empirical Bayes approach




). In practice, a numerical algorithm such
as Newton-Raphson is required to obtain these parameters. Note that in the next two
sections, we use
rx = ry = r, αx = αy = α, βx = βy = β, (5.16)
ηx = ηy = η, wx = wy = w, ax = ay = a, bx = by = b,
in order to simplify the computation of the parameters. However, different parameters
for X and Y were also tried, and no loss in terms of fit or in terms of error rates was
observed by assuming (5.16).
As we did in Chapter 3, the posterior probability of the one-sided alternative hypothesis
was computed for each gene. Note that due to the re-parametrization in the conjugate and
non-informative models, the one-sided alternative hypothesis is written as H ′1i : 1/θxi >
1/θyi in these two cases. From the results of Theorem 2.2, the posterior probability
pi obtained is asymptotically uniformly distributed on the interval [0, 1] under the null
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hypothesis, when m is large enough. It follows that this posterior probability can also be
applied in the Benjamini-Hochberg procedure, for example. Note that the exact procedure
used in the next sections was described in Section 2.4.
5.2 Goodness of fit study
Before applying the multiple testing procedure developed in the second chapter to the
inverse Gaussian models presented in this chapter, we believe that it is appropriate to
first perform a goodness of fit study, and compare it with the conjugate gamma model
used previously.
5.2.1 Application to four microarray datasets
In this section, we apply the two informative inverse Gaussian models described in Section
5.1.2 and 5.1.4 to four microarray datasets. These datasets have been described and used
in Chapter 3, Section 3.3. As we did for the gamma model, the histograms of the data
(on the log scale) were plotted against the predictive density functions (on the log scale)
for each dataset. The predictive density function of the non-informative inverse Gaussian
model being non-proper, this model is not used here.
For a better comparison between the gamma model and the two inverse Gaussian mod-
els, the fit for the three models is presented for each set of data in Figures 5.2, 5.3, 5.4, 5.5.
Throughout this section, the models are labeled IG/Norm for the conjugate inverse Gaus-
sian and IG/IG for the last inverse Gaussian model presented. The hyperparameters of
the two inverse Gaussian models used here are also presented in Table 5.1. We note the
good agreement between the gamma model presented in Chapter 3 (see Table 3.2) and
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Dataset IG/IG/G IG/Norm/G
η = 4184.06 α = 7.5 × 10−6
TCDD w = 0.027 β = 3251.8
a = 8, b = 0.62 r = 1.397
p = 0.018 p = 0.00108
η = 5912.18 α = 4.5 × 10−6
COLD w = 0.036 β = 3296.1
a = 2, b = 0.218 r = 1.25
p = 0.159 p = 0.082
η = 832.96 α = 3.6 × 10−5
DBLFLIP w = 0.029 β = 412.7
a = 2, b = 0.1144 r = 1.34
p = 3.5 × 10−4 p = 5.57 × 10−8
η = 7274.8 α = 6.4 × 10−6
FIELD w = 0.0435 β = 3693.8
a = 2, b = 0.222 r = 1.35
p = 0.250 p = 0.125
Table 5.1: Hyperparameters for the 2 informative inverse Gaussian models
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Figure 5.2: Fit for the 3 informative models: TCDD dataset
the IG/IG model, regarding the estimation of the parameter p. However, the fact that
the IG/Norm model provides estimates of p that are very different from the other two
models may be due to a lack of fit. By looking at the histograms, we note the very
poor fit provided by the conjugate model, to the four datasets. This is probably due to
the restriction imposed by this model, especially regarding the fact that the mean of the
data is assumed to be symmetrically distributed (normal distribution). So, even if this
model has the advantage of being conjugate and computationally easy to handle, it is
not adequate to describe microarray data. Again, this illustrates the importance of the
choice of the prior distribution in Bayesian or random effects models. However, we note
that the fit provided by the gamma and the IG/IG model is in general not bad. Note that
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Figure 5.3: Fit for the 3 informative models: DBLFLIP dataset
the performance of these two models strongly depends on the characteristics of the data,
and neither of the two models is better than the other for all four sets of data. However,
regarding the DBLFLIP dataset, it is obvious that the gamma model provides a better
fit. For the FIELD data, the opposite is true, with an excellent fit provided by the IG/IG
model. In order to compare the fit provided by these models with the fit obtained if the
model was true, we simulated two datasets according to the GAM and IG/IG models.
The predictive distribution of each model was then plotted against the histogram of the
data. This plot is presented in Figure 5.6.
In order to compare the fit provided by the models to the different datasets mathemati-
cally, three statistics were used, derived from three distribution-free tests of goodness of
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Figure 5.4: Fit for the 3 informative models: COLD dataset
fit. For instance, we consider a random variable X with unknown continuous distribution
function FX(x) and we want to test the null hypothesis H0 : FX = F0, where F0 is a
completely specified distribution function. In our case, the function F0 is the distribution
function induced by the marginal m(x
e
) for the two models. The three statistics we use
here are based on measure of the “distance” between F0 and the empirical distribution
function Fn(x). We note that our interest focuses more on the values of the test statistics
(in order to compare the models) rather than in the tests themselves. The three statistics
used here are the Kolmogorov-Smirnov statistic, the Cramer-von Mises statistic and the
Anderson and Darling statistic. Considering n random variables X1, . . . , Xn with dis-
tribution FX(x) and order statistics X(1), . . . , X(n), we define the Kolmogorov -Smirnov
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Figure 5.5: Fit for the 3 informative models: FIELD dataset
statistic as
Dn = Sup−∞<x<+∞|Fn(x) − F0(x)| = max(D+n , D−n ),
D+n = Sup−∞<x<+∞Fn(x) − F0(x) = max1≤i≤n{i/n− F0(X(i))},
D−n = Sup−∞<x<+∞F0(x) − Fn(x) = max1≤i≤n{F0(X(i)) − (i− 1)/n)}.
Then, this statistic represents the maximum distance between the F0 and the empirical
distribution function of X. A second type of distance measure, the Cramer-von Mises
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Figure 5.6: Fit for the GAM and IG/IG models: Datasets are simulated according the
right model




















One of the features of the first two statistics is that they are more sensitive to departures
in the middle of the range of F0(x). In our case, the main feature of microarray data is the
long tail of the distribution. It would then be interesting to have a measure focusing also
on the last part of the range of F0(x). The Anderson and Darling statistic is a weighted
version of the Cramer-von Mises statistic by a non-negative weight function ψ(u). In
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Kolmogorov Cramer Anderson
TCDD: Gamma 0.115 0.004 243.058
IG/IG 0.074 0.002 107.549
DBLFLIP Gamma 0.017 7.12 × 10−5 72.57
IG/IG 0.050 0.000 539.70
COLD Gamma 0.088 0.003 1125.78
IG/IG 0.047 0.000 458.233
FIELD Gamma 0.147 0.001 291.32
IG/IG 0.052 4.77 × 10−5 36.5
Table 5.2: Goodness of fit distances for the Gamma model and for the IG/IG model, for
the four datasets
particular, ψ(u) = n/[u(1 − u)] is considered here. The statistic is then defined as















(2i− 1)log(F0(x(i))) + (2n− 2i+ 1)log(1 − F0(x(i)))
]
.
Regarding the four datasets studied, goodness of fit distances for the IG/IG models
and the gamma model are presented in Table 5.2. These distances were not computed
for the conjugate inverse Gaussian model, since by looking at the histograms of the fit,
it is obvious that this model does not provide an adequate fit to the data. By analyzing
the results from Table 5.2, we note that for all the datasets, except for the DBLFLIP,
the inverse Gaussian model performs better than the gamma model, with respect to the
distances defined, Kolmogorov, Cramer and Anderson. In the case of the three datasets
TCDD, COLD and FIELD, we can conclude that the inverse Gaussian model is more
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Dataset Model Kolmogorov Cramer Anderson
Gamma Gamma 0.01913 0.00114 52.729
Gamma Inverse Gaussian 0.084 0.00287 178.203
Inverse Gaussian Gamma 0.1186 0.00548 268.83
Inverse Gaussian Inverse Gaussian 0.01568 6.52 × 10−5 3.82
Table 5.3: Robustness to the misspecification of the true distribution of the data, for the
non conjugate inverse Gaussian model and for the gamma conjugate model
appropriate than the gamma model to describe the behavior of the gene expressions.
5.2.2 A simulation study: Goodness of fit and robustness
In this section, we study the robustness of the inverse Gaussian models, compared to the
gamma model, in terms of goodness of fit. In order to do so, we simulated two sets of 100
datasets each. The first set of data were simulated according to the gamma model, with
parameters α = 9, α0 = 0.8, ν = 91 and p = 0.1, as in Kendziorski et al. (2002). The
second set of data was generated according to the non-conjugate inverse Gaussian model
defined in Section 5.1.4, with parameters p = 0.250, η = 7274.8, w = 0.0435, a = 2 and
b = 0.222 (as estimated in the FIELD dataset). Both models were fitted to the two types
of datasets. Note that for the same reasons as before, the non-informative model was not
applied here since its goodness of fit cannot be measured using the predictive distribution
function. Furthermore, as we have seen in the previous section, the fit provided by the
conjugate inverse Gaussian model was very poor, and for this reason, it was not considered
here. Table 5.3 presents the average goodness of fit distances (as defined in the previous
section) over the two types of 100 datasets. Of course, as expected, the fit provided to
the simulated data is always better when the true model is applied, for the three types
of distances chosen. However, if we look at the results when the model is misspecified
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(Gamma data with IG/IG model, or inverse Gaussian data with the gamma model), we
note that the difference between the good specification and the misspecification is much
less important when the inverse Gaussian model is applied. These results may indicate
that the inverse Gaussian model studied here is the most robust to the misspecification
of the model. Note that this is a great advantage when one works with microarray data,
since the true distribution of the data is hardly known and subject to many unknown
factors.
5.3 Multiple testing using inverse Gaussian models:
a simulation study
In this section, we apply the multiple testing procedure described in the second chapter,
and reviewed in Section 5.1.5, using posterior probabilities based on the inverse Gaussian
models.
5.3.1 Error rates and robustness
Since the results of the previous section showed a very poor fit when the conjugate model is
used, only the non-conjugate and non-informative models are used here. In order to study
the robustness of these models in terms of error rates, data were generated according to
the non-conjugate inverse Gaussian model, and according to the gamma model presented
in Chapter 3. Results were then compared with those using the posterior probability
computed under the gamma model. Specifically, two sets of 500 datasets were generated.
The first set is based on the non-conjugate inverse Gaussian model, with parameters
η = 7274, w = 0.0435, a = 2, b = 0.222, p = 0.23, corresponding to those obtained
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Dataset Model FDR FNR SENS SPEC RISK
GAMMA Gamma 0.049 0.066 0.763 0.988 0.063
SIMULATED IG/IG 0.017 0.079 0.710 0.996 0.069
DATA IG/NI 0.016 0.094 0.649 0.996 0.082
IG Gamma 0.1214 0.055 0.809 0.96 0.069
SIMULATED IG/IG 0.038 0.056 0.802 0.990 0.052
DATA IG/NI 0.031 0.073 0.73 0.99 0.065
Table 5.4: Error rates for the three models, for each type of dataset. FDR was controlled
at a level of 5%.
with the FIELD dataset. The second set of data was also generated according to the
parameters obtained by fitting a gamma model to the FIELD data, with α = 5.309,
α0 = 0.9579, ν = 325.83, p = 0.23. In both cases, n = 1000 genes were simulated, with
m = 10 replications each. For each set of data, the three models were fitted: IG/IG,
IG/NI (for the non-informative model) and Gamma. For each of them, the average error
rates were recorded. Results are presented in Table 5.4. Of course, we expect best results
for the model from which data were generated. However, we observe that the error rates
provided by the non-conjugate inverse-Gaussian model, when applied to gamma data,
are very low, especially for the False Discovery rate. It seems that this model is robust
enough to provide a low rate of False Discoveries, without a great loss in False Negative
Rate, or in RISK. The opposite, regarding the gamma model, is not true. It seems that
this model is not robust enough to provide an adequate control of the FDR (12%) when
data are generated under the inverse Gaussian model. Finally, the performance of the
non-informative model is not as good as expected: this model seems to be somehow
robust to the true distribution of the data, but provides a very low FDR, compensated
by a high FNR.
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5.3.2 Asymptotic study
The multiple testing procedure we use is based on the asymptotic (when m is large)
uniformity of the posterior probabilities pi under the null hypothesis (see Theorem 2.2).
Note that no result similar to the gamma model (Theorems 3.1 and 3.2), whose uniform














































Figure 5.7: Posterior probability pi under H0 for m = 5, m = 10 and m = 20. Results
based on a single simulated dataset
ure 5.7 shows histograms of the probabilities pi under the null hypothesis, for m = 5,
m = 10 and m = 20. These results are based on a single simulated dataset, generated
under the non-conjugate inverse Gaussian model, with η = 810.6, w = 0.068, a = 2,
b = 0.266, p = 0.05 and n = 1000. We can really see that the property of uniformity
seems to be approximately true, even for small value of m, and non-asymptotic results
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should hold in this case. However, our research in this direction is still preliminary, and
we leave this aspect to future research.
5.4 Discussion
We have introduced in this chapter three hierarchical models involving the inverse Gaus-
sian distribution, from which posterior probabilities can be derived similarly to the gamma
model presented in the last two chapters. Using the results from Theorem 2.2, these prob-
abilities are used in the same multiple testing procedures based on the control of the False
Discovery Rate.
With the study of four datasets presenting different characteristics, it appears that the
conjugate Inverse Gaussian model is not a good candidate to describe the behavior of
gene expression data. However, the non-conjugate model provides a very good fit to these
different types of data and may be a better alternative to the gamma model, in some situ-
ations. The flexibility of this model comes from the combination of two inverse Gaussian
distributions used for the raw data and its mean, and it appears to be really suitable to
describe long tail datasets, typical of microarray data. Furthermore, we showed through
a simulation study that this model has some attractive robustness properties that the
Gamma model does not show. We note that this could be explained by the fact that
the inverse Gaussian model has one more level of randomness, compared to the gamma
model, by assuming a prior distribution on the shape parameter. Such an assumption in
the gamma model would greatly complicate the computation of the posterior distribu-
tions and we leave this aspect as a future work.
The use of the posterior probability of the half-space provides an adequate control of the
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False Discovery level, as we showed in our simulation. Again, with respect to the error
rates studied, the inverse Gaussian model tends to be more robust to the true distri-
bution of the data than the gamma model. Finally, we note that the results we used,
regarding the multiple testing procedure developed, are valid asymptotically, when m is
large enough. However, it seems that this property is valid not only asymptotically, and
further investigation is needed in order to obtain non-asymptotic results similar to the




genomics to discover genes
important in abiotic stress tolerance
This is a four year project (April 2001-March 2005) supervised by Marilyn Griffith and
Barbara Moffatt, from the Department of Biology of the University of Waterloo, and by
Elizabeth Weretilnyk, from the Department of Biology of McMaster University. It also
involves two bio-informaticians, Brian Golding and Paulo Nuin, both from the Biology
Department at McMaster University. The main goal of the project is the identification of
genes essential to the development of abiotic stress tolerance in the crucifer Thellungiella
salsuginea. In a long term, this information will ideally be used to improve the stress
tolerance of canola varieties.
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6.1 Overview of the project
Thellungiella salsuginea is a plant from the wide family of crucifers, the member of which
grow in many different types of habitats, ranging from alkaline mudflats to meadows,
thickets, beaches and burnt-over woods. It has been found that this plant is extremely
tolerant of abiotic stresses, and in particular shows a high freezing, salt and drought
tolerance. Thellungiella salsuginea is also found in the region where the majority of
Canada’s canola crop is produced. The discovery of genes responsible for the different
types of stress tolerance in Thellungiella would then be of high interest, in order to im-
prove stress tolerance, and then productivity in canola. So far, among the crucifers, the
genetic components of abiotic stress tolerance have been best characterized in Arabidopsis
thaliana (see Motoaki & Mari (2002)), the model plant used internationally for studying
plant molecular genetics. Furthermore, it has been shown that Arabidopsis and Thel-
lungiella plants are closely related, in terms of their genetic information (see Bressan,
Zhang, Zhang, Hasegawa, Bohnert & Zhu (2002)). The main strategy of the project
is then to exploit the extensive genetic knowledge amassed for Arabidopsis to discover
genes involved in stress tolerance in a plant that exhibits a significantly greater capacity
to survive saline, drought and freezing conditions.
6.2 Experiment pre-processing
The microarray experimental procedure requires two essential steps. First, it requires the
preparation of the biological samples of interest. In this particular case, Thellungiella
seeds were collected from the Takhini Salt Flats, in the Yukon, and were grown under
different controlled environmental conditions to determine the level of freezing, salt and
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drought tolerance of the plant. For each salinity/temperature/drought condition, total
RNA was prepared from the leaves of the plant, from which mRNA was isolated. In addi-
tion, “control” plants were grown under identical light and temperature condition except
for stress (ie. normal temperature with absence of salt or drought stress) and mRNA
was isolated as well. During the microarray experiment, the mRNA obtained from plants
grown under two different conditions is labeled and hybridized to the cDNA sequences
printed on the array. Note that in this case, expression information will be obtained only
from the genes printed on the array.
First, cDNA is synthesized from plants grown under conditions known to provoke the
accumulation of transcripts associated with cold acclimation, freezing tolerance, drought
and salt stress. This is done by using an experimental technique called reverse transcrip-
tion, where mRNA strands are used to synthesize double strand complementary DNA
(cDNAs). A cDNA clone is a section of cDNA that has been inserted into a vector
molecule to form many copies.
For the project, five cDNA libraries were created, using RNA from different tissues ac-
climated to cold, salt and freezing conditions. At this point, each cDNA was sequenced.
Using the close genetic connection between Arabidopsis and Thellungiella, this was done
by conducting a BLAST search analysis against the Arabidopsis genomic sequence data-
bank for identification of the genes and their map positions in the Arabidopsis genome.
Finally, in order to have a sufficient quantity of each cDNA clone to print on the array,
each clone was amplified using a technique called PCR (polymerase Chain Reaction). It
is the PCR product that is actually printed on the array.
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6.3 Design of the microarray
Treatment 1 Treatment 2
Experiment 1 Cold Control
Experiment 2 Drought Control
Experiment 3 Salt Control
Experiment 4 Drought Rewater
Experiment 5 Field Control
Table 6.1: The four experiments
The five different microarray experiments that were conducted for this project are
presented in Table 6.1. For some technical reasons, the five experiments were conducted
and analyzed separately. While all the treatments could be combined together in a loop
design (see Kerr & Churchill (2001a)), we used instead a replicated latin square design for
each of the experiments. For each experiment, six chips were used, using three biological
replications and a dye-reversal strategy. The design is illustrated in Table 6.2. The
Green dye Red dye
Array 1 Treat.1-Sample A Treat.2-Sample A
Array 2 Treat.2-Sample A Treat.1-Sample A
Array 3 Treat.1-Sample B Treat.2-Sample B
Array 4 Treat.2-Sample B Treat.1-Sample B
Array 5 Treat.1-Sample C Treat.2-Sample C
Array 6 Treat.2-Sample C Treat.1-Sample C
Table 6.2: experimental design
biological replications A, B and C correspond to mRNA extracted from three pools of
different plants, grown under the same conditions. We also note that the exact same set
of genes (in the same order) was printed on the 6 arrays used for each experiment. Each
gene was spotted three times (on adjacent spots) on each array. Thus, 36 expression
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measurements are available for each gene, for each experiment. We mention that it is
rare, in the literature, to see cDNA microarray datasets with so many replications. This
extra effort allows us to get good estimates of the different sources of variation and the
data available are then more reliable than many datasets available to the public.
In total, 4896 genes (PCR products from cDNA clones) were spotted on each array, and
of these 125 are control spots. These controls consist of 96 spiked genes that should be
constantly equally expressed under any type of treatment, and of 29 buffer-only spots
where no hybridization should occur. In this last case, no cDNA was printed on the spot
and we should not obtain a positive value of the expression associated to these spots.
Finally, we note that each array is divided in 48 sub-arrays, represented by a 12 × 4
matrix of sub-arrays, and each sub-array can be represented by a 17×18 matrix of spots.
Then, on each sub-array, 102 different genes are spotted, 3 times each.
In this chapter, we focus our attention on the analysis of the Cold, Drought and Salinity
experiments. The variability of each gene within the three spots being quite large, we
decided to take the median of the three spots as a unique measure of expression, for each
array-treatment combination. Thus, a total of 12 measurements for each gene were used.
Finally, note that genes having intensities within the three replicated spots that differed
by more than 2.5 fold were removed from the data. Plots of the raw data log(X) versus
log(Y ) are presented in Figures A.3, A.4 and A.5. New datasets sizes are presented in
COLD DROUGHT SALINITY
4853 4891 4835
Table 6.3: Size of each datasets. Initial datasets contain 4896 genes.
Table 6.3.
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6.4 Normalization of the data
Due to the high variability of the expression data, a normalization procedure had to
be performed on each array, for each experiment. This process of removing systematic
effects is divided into three steps (see Cui, Kerr & Churchill (2002)). First, the back-
ground correction consists of subtracting the background intensity from the fluorescent
signal at each spot. Then, the data transformation, applied to one microarray at a time,
removes systematic effects from the log-ratios (Red/Green). Finally, the data normal-
ization process calibrates the signals from different channels and arrays to a comparable
scale. Regarding the data transformation (of each individual array), we observe two com-
mon features in microarray data that can be the result of a problem occurring during
the hybridization step. The first one is the dependence of log-ratios on spot intensity
and the second one is the spatial variation of the log-ratios, over the different sub-arrays.
Since cDNA clones are typically spotted in a random fashion, one should not see any
strong association between expression and the spatial region (sub-array) of a slide. The
first type of dependence can be diagnosed by viewing a plot of the log-ratios versus the
average of the log-intensities (over the two dyes). This type of representation is referred
to as a RI plot (Ratio by Intensity), or MA plot and was first introduced by Yang et al.
(2002) in the context of microarray data. Under the assumption that most of the genes
are not differentially expressed (which should be the case in a large genomic study), most
points of the RI plot should fall along an horizontal line, if no problem occurred in the
hybridization. The second type of dependence (spatial heterogeneity) can be diagnosed
by plotting, for each sub-array, the intensity of the red channel versus the green chan-
nel. If no problem in the hybridization occurred, the red and green intensities should be
highly correlated and we should see a nearly linear curve in all plots. There are many
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data transformation methods available that correct for the former type of dependence.
We chose to use the one developed recently by Cui et al. (2002), called the joint LOWESS
method. It has the main advantage of combining two standard approaches, the intensity
LOWESS correction and the spatial LOWESS correction (see Yang et al. (2002) for more
details) to correct for intensity dependent bias and spatial bias simultaneously. Then, for







− Cg(Ig, row, col),
where Ig = (log(Xred,g) + log(Xgreen,g))/2,
and where Cg is a constant that depends on the location of the spot g on the array (col,
row) as well as the average intensity Ig. This constant is determined by the common
curve fitting LOWESS procedure. Here, X refers to the expression value for a particular
spot and a particular dye on the array. We note that if a linear function is used for the
local regression, the procedure is then referred to as the joint LOESS procedure.
As an example of such correction, RI plots, where a strong trend is observed before
correction, are presented in Figures 6.1 and 6.2. These plots correspond to the second
and fifth arrays of the Cold and Salinity experiments, respectively. We can see that, for
these two arrays, a trend was clearly noticeable before transformation, that was corrected
by the joint LOWESS procedure.
Finally, in order to normalize the data between arrays and treatment to a comparable
scale, the procedure described in Section 4.2.1 was applied.
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Figure 6.1: RI plot: Array2, Cold dataset
6.5 Results
We applied the three procedures developed in this thesis to the three datasets. The pro-
cedure involving the conjugate gamma model, described in Chapter 3, is denoted GAM.
Its generalization to a multiplicative model accounting for the gene-array and gene-dye
interactions, described in Chapter 4, denoted as GAM.MUL. As we did in Chapter 3,
2500 iterations were used in the Gibbs sampling algorithm, and starting values were
generated according to the prior distribution of the gene-specific effects. Finally, the
procedure based on a inverse Gaussian model, as described in Chapter 5, is denoted IG.
Note that the multiplicative gamma model is the only method that takes into account
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Figure 6.2: RI plot: Array5, Salinity dataset
the array-gene and the dye-gene interactions. However, we recall that data have been
previously normalized to account for a global array, treatment and dye effects. We finally
mention that for each model, genes have been detected at a FDR level of 1%.
First, let us evaluate the fit provided by the models, to the three datasets. The
quantile-quantile plots, regarding the multiplicative gamma model as described in Sec-
tion 4.3.1, are presented in Figures 6.3, 6.4, and 6.5 for the Cold, Drought and Salinity
datasets, respectively. We note that these quantile plots can hardly be compared with
those involving the histogram and predictive distribution of the data (as for the gamma
and inverse-Gaussian models). The main issue in such plots is that in the case of the
multiplicative model, the predictive distribution cannot be computed easily. A partial
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Figure 6.3: QQplots for the multiplicative gamma model: Cold dataset
solution to this problem is then to correct the data for the array and dye gene-specific
effects, using the posterior expectations obtained from the multiplicative model. A simple
gamma model can then be fitted on the data arising from the two types of treatments,
as we did in Chapter 3. The histograms of such corrected data (on the logarithm scale),
with the associated predictive distribution, are presented in Figure 6.6. The predic-
tive distributions (on the logarithm scale) versus the histogram of the intensities are also
presented in Figures 6.7 and 6.8 for the GAM and IG models respectively. Note that
these histograms are not identical to those of Figure 6.6 since in this case, data have
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Figure 6.4: QQplots for the multiplicative gamma model: Drought dataset
been corrected for the gene-specific dye and array effects. First, these figures confirm
the fact that there is no universal “best model” in microarray data, and that intrinsic
features of the data determine which model is the most appropriate. Up to now, these
features have not been discovered, and a goodness of fit study of several models seems
an appropriate choice. Figures 6.5 and 6.6 both suggest that the multiplicative gamma
model is the most appropriate for the SALINITY dataset. The quantile-quantile plots of
the COLD and DROUGHT data clearly show a deviation from the gamma (especially for
the DROUGHT) and this model is not appropriate in this case. We also note the small
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Figure 6.5: QQplots for the multiplicative gamma model: Salinity dataset
bias in the boxplots of the residuals for these two datasets, with a median and average
of 0.95 instead of 1, as we could expect. Figures 6.7 and 6.8, which show the predictive
distributions for the IG and GAM models seem to suggest that the IG model is more
appropriate than the GAM model for both the DROUGHT and COLD data. Note that
such a statement could be verified with the help of the goodness of fit distances described
in Section 5.2.1 (results not shown here).
The number of genes detected by the three models is presented in Table 6.4. By look-
ing at the results, we can observe the same pattern, regardless of the type of dataset
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Figure 6.6: Predictive distribution for the MUL model, for the three datasets, corrected
for the gene-specific array and dye effects
GAM.MUL GAM IG
COLD 337 < − 160 common − > 162 < − 113 common − > 116
DROUGHT 295 < − 195 common − > 202 < − 108 common − > 115
SALINITY 266 < − 60 common − > 62 < − 25 common − > 26
Table 6.4: Number of genes detected. Numbers in bold represent the number of genes
detected by the most appropriate method, according to the goodness of fit study.
analyzed. The gamma multiplicative model seems to be the least conservative approach,
and detects more genes than the other models. On the contrary, the inverse Gaussian
model is the most conservative model leading to the detection of fewer genes. An extreme
illustration of this pattern is shown in the SALINITY dataset, with which the IG model
detects only 26 genes, versus 266 genes for the multiplicative gamma model. Note that
in this specific case, GAM.MUL seemed the most appropriate model, as we concluded
from the goodness of fit study. However, it seems that the three models agree pretty well
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Figure 6.7: Predictive distribution for the GAM model, for the three datasets
in the list of genes detected since most of the genes from a short list also appear in the
longer list. Furthermore, we note that none of the buffer-only genes (not expressed in
any of the treatments) and the spiked genes (equally expressed controls) were detected
by any of the models. A similar statement holds for 5 genes (ACTIN2, TUBULIN, EIF,
UBQ10 and PIP) printed several times across the arrays, known in the literature to be
equally expressed (constitutive genes) under the three types of treatments studied. For
a visualization of which genes are detected by each method, we refer to the Figures B.1
to B.6 for the COLD dataset, to Figures C.1 to C.6 for the SALINITY dataset and finally,
to Figures D.1 to D.6 for the DROUGHT dataset.
In addition to these constitutive genes, some positive genes have also been printed on the
arrays. For instance, the gene COR15, known in the literature to be induced under the
COLD treatment, was printed 3 times on each array. The three occurrences of this gene
have been detected by the three models for the COLD dataset. Another gene, FL5-2D23,
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Figure 6.8: Predictive distribution for the IG model, for the three datasets
known to be induced in DROUGHT was also printed in three copies. The 3 occurrences
were detected by the GAM.MUL and GAM model, whereas only 2 occurrences were
detected using the IG model, for the DROUGHT dataset. Note that these same three
occurrences were also detected by the all the models in the SALINITY dataset.
6.6 Discussion
From the analysis of the three datasets described, we can draw several conclusions. First,
as we mentioned, it is very hard to find a model that can describe adequately microarray
data, in general. We believe that several models should be applied to the datasets, and
a goodness of fit study should be performed in order to know which model fits best. In
our case, the quantile-quantile plots, or the histograms versus the predictive distribution
plots are both good indicators of goodness of fit. In addition, the use of controls is very
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important (positive and negative) in order to ensure the quality of the results. In our
case, the three models agree in this sense, since the known positive genes were detected by
the three models and the spiked genes as well as the constitutive genes were not detected.
Finally, we mention that the feature of the data may depend of several unknown factors,
and we note that in our case, even if the three datasets come from the same laboratory,
and were built in the same technical conditions, we observe a variation in the type of
model that should be used. However, we still believe that Bayesian or random effects
models should be preferred to frequentist one, since these models deals easily with a small




In this chapter, we outline some future research projects, that would allow us to gen-
eralize or link some of the results presented in the previous chapters to another area
of statistical genetics. In particular, we first consider the possibility of developing a
multiplicative model, similar to the one presented in Chapter 4, involving the inverse
Gaussian model. Furthermore, motivated by a paper from Scholten, Miron, Merchant,
Miller, Miron, Iglehart & Gentleman (2004), we consider extending the multiple testing
procedure developed in this thesis to more than two treatments. Finally, we would like to
explore the possibility of linking gene expression data with some specific DNA sequences
corresponding to the genes, through a problem called DNA motif discovery.
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7.1 A Multiplicative ANOVA model for inverse Gaus-
sian data
As we have seen in Chapter 5, inverse Gaussian models can provide a very powerful
alternative to the traditional gamma models. Specifically, these models demonstrate
properties of robustness to the true distribution of the data that are very appealing,
especially for microarray data whose distribution may vary a lot from one laboratory to
another. Furthermore, results regarding the uniformity of the posterior probability pg
under the null hypothesis do not seem to be affected by a small number of observations.
Regarding the non-informative model, we believe that computations of the posterior
distribution of the gene-effects would be tractable, under the model




















using the same notations as in Chapter 4. However, computations would become much
more challenging if one wanted to work with a model similar to the non-conjugate one,
presented in Section 5.1.4. Clearly, it would be interesting to see if such a model can be
integrated into the multiplicative framework presented in the fourth chapter.
7.2 Generalization to more than 2 treatments
In this thesis, we considered the particular case of two treatments. The multiplicative
model presented in Chapter 4 can be applied to more than two treatments, but how the
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multiple testing issue should be considered in this case remains an open question. Suppose






respectively. The three treatments means, for each gene g, are noted θxg, θyg and
θzg respectively and we are interested in testing the null hypothesis H0 : θxg = θyg = θzg.
Note that the parameter space is then R3. With such a space, a half-space would be de-
fined as {θ
e
∈ R3 : v1θx+v2θy +v3θz ≥M} with M ∈ R and |v1+v2 +v3| = 1. Taking the
posterior probability of such a space may not be very meaningful in many cases. We may
then think about two alternative ways of testing the hypothesis H0. The first solution
would be to consider the alternative hypothesis H1 : At least one of the θ’s is different,
and then consider the one-sided alternative Ha1 : θxg > θyg > θzg. In such a case, note
that Ha1 represents 1/6 of the total space and thus cannot really be seen as a “one-sided”
alternative hypothesis. Such considerations are the object of current work and it can be
shown that the computation of P (Ha1 |data) involves the knowledge of the joint distribu-
tion of Z|X and Z|Y , which we are currently trying to derive.
The second solution we propose is an iterative solution. First, the null hypothesis H
(1)
0 :
θxg = θyg is tested using the posterior probability of the half-space P (θxg > θyg|data).
This can be done using the approach developed in Chapter 2. Taking only the sub-
set of genes from which H
(1)
0 was not rejected, we can consider the parameter space
{(θx, θy, θz) ∈ R3 and θx = θy}. Under such a parameter space, we consider the null hy-
pothesis H
(2)
0 : θxg = θyg = θzg and the one-sided alternative as H1a : θxg = θyg and θyg >
θzg. Again, the probability P (H1a|data) represents the posterior probability of the half-
space of the space considered and results presented in this thesis can be used. Such an
iterative procedure can be generalized to any number of treatments and any type of con-
trasts tested. The main idea is then to take, in an iterative manner, the half-space of the
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ES present ⇒ Gene A expressed.
Production of a protein called
Transcription Factor (TF)
⇓
TF binds to the promoter region ⇒ Expression of Gene B is induced
of Gene B by the TF
Table 7.1: illustration of primary and secondary ES target genes
space under which a null hypothesis is tested.
A very interesting motivation and application regarding the generalization of our
work to several treatments is the experiment described in Scholten et al. (2004). This
paper emphasizes the fact that microarray experiments can be very efficiently designed by
interpreting the biological questions in terms of the statistical parameters. In this specific
case, 32 affymetrix arrays, from a 24 factorial design experiment with 2 replications each,
were printed. Data come from an experiment on cells from an estrogen receptor positive
human breast cancer cell line. Among the four 2-level factors studied, two are of particular
interest: cyclohexamide (CX, present or absent) and estrogen (ES, present or absent).
One of the goals of the study is to detect ES target genes (genes differentially expressed
under the presence of estrogen) and among them, differentiate between the primary and
secondary targets.
The definition of primary and secondary ES target genes is illustrated in Table 7.2. In
this table, Gene A is a primary ES target since its expression is directly induced by the
presence of ES. On the other hand, Gene B is called a secondary ES target since its
expression is the results of the production of a transcription factor by the primary ES
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Conditions 1 2 3 4 5 6 7 8
θ0 6= θ1 No Yes Yes Yes No Yes Yes Yes
θ0 6= θ2 Yes No Yes Yes Yes No Yes Yes
θ0 6= θ3 Yes No Yes No No Yes Yes Yes
θ3 6= θ1 Yes Yes Yes Yes No No No No
θ3 6= θ2 No No Yes Yes Yes Yes Yes Yes
θ1 6= θ2 Yes Yes No Yes Yes Yes Yes Yes
Table 7.2: Situation that may occur when genes are ES targets. Situations 1-4 represent
primary targets and situations 5-8 represent secondary targets
target gene A.
We consider here expression levels under four treatments, noted as
X0 : gene expression under both CX and ES absent,
X1 : gene expression under CX only,
X2 : gene expression under ES only,
X3 : gene expression under both CX and ES.
Note that the index g for each gene is omitted here. Suppose that (X0, X1, X2, X3)
have corresponding expression means (θ0, θ1, θ2, θ3). Under such a framework, if a gene
is an ES target, 8 types of biological situations may occur, that can be related to the
parameters as described in Table 7.2. Situations are labeled from 1 to 8. Primary ES
targets are represented by situations 1-4 and secondary ES targets by situations 5-8.
Using this table, we can see that testing if a gene is an ES target can be done by testing
the null hypothesis H0a : θ0 = θ1 = θ2 (representing the hypothesis that a gene is not
an ES target). Among the ES targets, secondary ES targets can be identified by testing
H0b : θ3 = θ1. Furthermore, genes could be clustered according to the type of biological
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situations they represent, by testing the hypothesis that a specific situation (shown in
Table 7.2) occurs.
7.3 Detection of regulatory motifs in DNA sequences
As we have seen through this document, microarray technology provides insights about
the level of expression of a set of thousands of genes in a cell, or differences in their
expression between two cells. If we go deeper into the principles of molecular genetics,
it is of interest to understand the biological mechanisms behind gene expression. It is
known that the expression of specific genes can be controlled by some proteins called
transcription factors. These proteins act by binding to short sequences of nucleotides,
located in the upstream region of the gene. These corresponding families of sequences
are distinctive and are referred as cis elements or motifs. Each occurrence of the motif in
the sequence is called a motif element. The knowledge of these sites is of course of high
interest for biologists.
One of the main issues with the discovery of new motifs is the variability of the motif
elements. For example, consider the 12 binding sites for a transcription factor called
the λ repressor, composed of 8 nucleotides each. It appears that only two of the eight
nucleotides are conserved over all the sites, whereas the other nucleotides have a range of
variability. We can then view the problem studied as detecting the occurrences of a word
(motif), in a text (DNA sequence) composed of four letters, A, T, G and C, where many
”typos” can occur. The motif is then described as a stochastic word and it is natural to
use probabilistic models to describe the motif pattern, as well as the associated statistical
properties to lead us in the discovery of these patterns.
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A motif of length w is represented by a Probability Weight Matrix (PWM) of size 4×w,
noted Θ = (θ1, . . . , θw). Each column j of the matrix, θ
T
j , represents a multinomial distri-
bution with four cell probabilities, θj1, . . . , θj4, representing the probability of occurrence
of the four nucleotides A, T, G and C. Several types of models have been developed and,
as a basis for our research, we consider the models developed by Keles, Van der Laan,
Dudoit, Xing & Eisen (2003) and Liu, Gupta, Liu, Mayerhofere & Lawrence (2004). In
both approaches, we consider the nucleotides of the DNA sequence arising from a two
component multinomial mixture model. The first component is called the background
model and assumes that the nucleotides observed at a particular site do not contribute
to the motif, but are independent and identically distributed according to a multinomial
distribution with parameter θ0 = (θ01, . . . , θ04). The second component of the model is
the motif model, described by the matrix Θ.
7.3.1 Statistical models
The first model we studied (Keles et al. (2003)) assumes zero or one occurrence of the
motif per sequence. The occurrence (or not) of the motif as well as the starting position
of the motif in the sequence are considered to be hidden variables. If the motif occurs
once, its starting position is assumed to be uniformly distributed over the length of the
sequence (minus the length of the motif). In this model, no prior distribution is assumed
on the parameters Θ and θ0, and the use of the E-M algorithm is required in order to
estimate these parameters. The authors of the paper also showed that it is possible to
impose some constraints on the PWM Θ, through its Information Content (IC) at a
149
position l of the motif, defined as





where J = 4 represents the number of letters in the “alphabet”. The constraints on the
information content of the matrix arise as a function of the position l in the motif and
examples of such constraints are the high-low-high or low-high-low information content
profiles. In the case of the constrained Probability Weight Matrix, estimates of the
parameters are also obtained using the E-M algorithm, but the computational complexity
of the problem requires the use of some programming techniques such as SQP (Sequential
Quadratic Programming). Inference about the motifs is made through the probability
that the motif starts at a specific location, and through the probability that there is one
motif occurrence in the sequence. In practice, we note that neither the length of the
motif, nor the type of constraint for the PWM (eg: low-high-low) are known. There is
the need here to search through a specified range of motif widths and the optimal width
is chosen by optimizing a model selection criterion. In the case of the paper studied, the
model selection method chosen is a likelihood-based cross-validation.
The second model (Liu et al. (2004)) deals with one or more motif occurrences per
sequence. The main difference between this model and the one described in the previous
section is the introduction of a Bayesian framework. Again, a hidden variable of the model
is the starting position of the motif in the sequence, but a Dirichlet prior is assumed on
the Probability Weight Matrix Θ and on the background probability vector θ0. The
parameters of the model are estimated using a Gibbs sampling technique. Furthermore,
no constraints on the PWM are assumed, but a sequential model approach can be used,
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that allows for some “holes” in the motif.
7.3.2 Linking gene expression data with motif finding analysis
Very few papers have been published that link gene expression with motif discovery. We
believe that the information available from gene expression (microarray data) could be
of great use in the search for new motifs. For instance, if genes are clustered based on
similarity in expression profile over a large number of different conditions, the upstream
regions of the genes in the cluster can then be analyzed for the presence of shared se-
quence motifs (see Bussemaker, Li & Siggia (2001)). Among the papers available linking
microarray data with motif discovery, we can cite Conlon, Liu, Lieb & Liu (2003) which
uses linear regression models between a motif-matching score and gene expression. The
algorithm they use can be summarized into 5 steps. First, the genes are ranked according
to their expression, and their upstream sequence is obtained. We note here that the genes
selected belong to a cluster of genes with high expression. Then, a computational method,
called Motif Scan Discovery (MDscan) is applied, that searches for DNA sequence motifs.
We refer to Liu, Brutlag & Liu (2002) for the details about this procedure, and we note
that the underlying statistical details (Bayesian model) can be found in Liu, Neuwald
& Lawrence (1995). This model is similar to the one described briefly in the previous
section. The next step of the algorithm is to construct a score, for each sequence, for
matches to each MDscan reported motif. For a motif m of length w and for a gene g, the






Pr( x from Θm)




where Θm is the PWM of the motif m, θ0 represents the background probability model
(here, a third order Markov chain model for the background is assumed) and Xwg is the
set of all w-mers (nucleotides sequences of size w) in the upstream sequence of gene g. In
the fourth step of the algorithm, a simple linear regression is performed, for each motif
m reported by MDScan, such that
Yg = α + βmSmg + εg,
where Yg is the log2 expression value of gene g and where εg is the gene-specific error term.
The motifs having a significant β coefficient are retained and the multiple regression model
is then fitted:





A stepwise regression procedure is finally applied, to detect the group of motifs acting
together to affect gene expression.
As we can see, the problem of motif discovery can be divided into two different aspects:
the construction of statistical models that allow us to obtain a list of potential motifs from
the n DNA sequences, and the construction of a model linking gene expression with a
score for each motif. Regarding the first aspect of the problem, we would like to consider
a model with zero, one or more occurrences of the motif per sequence (we recall that the
models presented in section 6.2 assume zero/one or one/more occurrences of the motif per
sequence). As for the other models, the hidden variables considered would be the starting
position of the motif in the sequence, as well as its number of occurrences. For instance,
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we could define the variable Yk such that Yk = 1 if there is at least one occurrence of
the motif in the kth sequence, and Yk = 0 otherwise. We could consider the introduction
of a prior distribution on the variable Yk, such that we could assume the variables Yk
as being distributed according to a Bernoulli distribution with parameter pk, where pk
would be the posterior probability defined in the last two chapters, for the gene k. The
motivation behind this is that if the gene is differentially expressed under the treatment,
there is more chance to find a motif sequence that would induce the expression of this
gene under this treatment.
Furthermore, introducing some constraints on the Information Content of the Probability
Weight Matrix of the motif seems very appealing, and it would be interesting to find a
more general function for this constraint, that would be a function of some parameters
such that it could accommodate a variety of array shapes. The selection model procedure
would then be defined on the length of the motif as well as on the parameters of the
Information Content.
Regarding the second aspect of the problem of finding new motifs, we could use the
work from the previous chapter by using the normalized gene expression ratio of the two
treatments (using the posterior expectations) as the dependent variable. The posterior
probability of differential expression could then be used as a weight for the motif score
(a big part of the significant genes have an estimated posterior probability of 1) in the





The main contribution of this thesis is the attempt to connect Bayesian analysis and
frequentist theory in a frequentist multiple testing framework. The half-space procedure
described in this document provides an interesting tool, allowing a posterior probability
to be considered in the same spirit as a p-value in such a context.
Two main points motivated our work. First, models using p-values are restrictive in many
aspects, but offer in the other hand the advantage of providing a control of frequentist
error rates, ie. that do not depend on the data. Inversely, Bayesian theory brings an
attractive flexibility to the models, but the control of posterior error rates can be criti-
cized. We can cite for example the weak repeated sampling principle, stating that ”we
should not follow procedures which for some possible parameter values would give, in
hypothetical repetitions, misleading conclusions most of the time” (see Cox & Hinkley
(1974)).
The linking of both approaches enables us to use the best of each simultaneously in a
unique procedure. The posterior probability pi we use is at the same time meaningful
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as a test statistic (we reject the null hypothesis for small values of pi), computed under
the posterior probability of the parameter of interest, and independent of the mixture
parameter of the model (proportion of true null hypotheses). This makes it a statistic
robust to a misspecification of this parameter, with the open possibility of using it in
the Benjamni-Hochberg procedure, or any of its extension using frequentist p-values to
control the False Discovery Rate. Note that the use of this type of probability was first
introduced by Ibrahim et al. (2002) as a measure of significance for each test. In this
paper, sub-models were created, for each threshold level δ such that H1i is rejected when
pi > 1 − δ or pi < δ, and the optimal model was chosen using a Bayesian criterion.
The method we propose is described in the context of microarray experiments in this
document. However, one should not limit its use to this type of datasets. If the case
of two dimensions is treated here, the approach finds also very good application in the
univariate case. Testing any hypothesis, in a Bayesian framework, of the form H0 : θ = θ0
can be done by considering the posterior probability of the half-space, P (θ > θ0|data),
and similarly, by using it as an input in the BH procedure. In this case, exact compu-
tation of such probability only requires the knowledge of the posterior distribution of θ,
which is often not difficult to obtain if the model is tractable enough. Note that in this
thesis, only one or two level for the hierarchy of the model were considered, but highly
hierarchical models could be used in a similar spirit.
The models we considered in the context of microarray data may be somehow ques-
tionable with respect to the independence assumption between genes. Modeling such
a dependence is very challenging and this is still an open research question in the mi-
croarray literature. However, hierarchical models seem to have the potential of modeling
certain dependence structure, as Ibrahim et al. (2002) showed, and more research in this
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area is certainly needed.
Bimodal models could also be considered successfully, and some preliminary work in this
direction shows that it could be the answer to the lack of fit provided by any models,
especially regarding the COLD and SALINITY dataset presented here. In such a case,
modeling low and high expressed models using a mixture of distribution seems to greatly
improve the model fit.
Finally, we want to mention that the tools developed in this thesis are especially appro-
priate for the analysis of two color microarrays, where using ratios is the predominant





















































































Figure A.1: Raw data: TCDD dataset
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Figure A.2: Raw data: DBLFLIP dataset
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Figure A.3: Raw data: COLD dataset
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Figure A.4: Raw data: SALINITY dataset
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Figure A.5: Raw data: DROUGHT dataset
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Figure A.6: Raw data: FIELD dataset
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Appendix B
COLD dataset: Plots of the gene
detected
166






























































































































































































































































































































Figure B.1: Genes detected: COLD dataset. The symbol ”1” represents the genes de-
tected by the inverse-Gaussian model. Symbols ”1” and ”2” represent the genes detected
by the GAM model (including those detected by the inverse-Gaussian model). Symbols
”1”, ”2” and ”3” represent the genes detected by the multiplicative gamma model
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Figure B.2: Genes detected: COLD dataset. The symbol ”1” represents the genes de-
tected by the inverse-Gaussian model. Symbols ”1” and ”2” represent the genes detected
by the GAM model (including those detected by the inverse-Gaussian model). Symbols
”1”, ”2” and ”3” represent the genes detected by the multiplicative gamma model
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Figure B.3: Genes detected: COLD dataset. The symbol ”1” represents the genes de-
tected by the inverse-Gaussian model. Symbols ”1” and ”2” represent the genes detected
by the GAM model (including those detected by the inverse-Gaussian model). Symbols
”1”, ”2” and ”3” represent the genes detected by the multiplicative gamma model
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Figure B.4: Genes detected: COLD dataset. The symbol ”1” represents the genes de-
tected by the inverse-Gaussian model. Symbols ”1” and ”2” represent the genes detected
by the GAM model (including those detected by the inverse-Gaussian model). Symbols
”1”, ”2” and ”3” represent the genes detected by the multiplicative gamma model
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Figure B.5: Genes detected: COLD dataset. The symbol ”1” represents the genes de-
tected by the inverse-Gaussian model. Symbols ”1” and ”2” represent the genes detected
by the GAM model (including those detected by the inverse-Gaussian model). Symbols
”1”, ”2” and ”3” represent the genes detected by the multiplicative gamma model
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Figure B.6: Genes detected: COLD dataset. The symbol ”1” represents the genes de-
tected by the inverse-Gaussian model. Symbols ”1” and ”2” represent the genes detected
by the GAM model (including those detected by the inverse-Gaussian model). Symbols
”1”, ”2” and ”3” represent the genes detected by the multiplicative gamma model
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Appendix C
SALINITY dataset: Plots of the
gene detected
173











































































































































































































































































Figure C.1: Genes detected: SALINITY dataset. The symbol ”1” represents the genes
detected by the inverse-Gaussian model. Symbols ”1” and ”2” represent the genes de-
tected by the GAM model (including those detected by the inverse-Gaussian model).
Symbols ”1”, ”2” and ”3” represent the genes detected by the multiplicative gamma
model
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Figure C.2: Genes detected: SALINITY dataset. The symbol ”1” represents the genes
detected by the inverse-Gaussian model. Symbols ”1” and ”2” represent the genes de-
tected by the GAM model (including those detected by the inverse-Gaussian model).
Symbols ”1”, ”2” and ”3” represent the genes detected by the multiplicative gamma
model
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Figure C.3: Genes detected: SALINITY dataset. The symbol ”1” represents the genes
detected by the inverse-Gaussian model. Symbols ”1” and ”2” represent the genes de-
tected by the GAM model (including those detected by the inverse-Gaussian model).
Symbols ”1”, ”2” and ”3” represent the genes detected by the multiplicative gamma
model
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Figure C.4: Genes detected: SALINITY dataset. The symbol ”1” represents the genes
detected by the inverse-Gaussian model. Symbols ”1” and ”2” represent the genes de-
tected by the GAM model (including those detected by the inverse-Gaussian model).
Symbols ”1”, ”2” and ”3” represent the genes detected by the multiplicative gamma
model
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Figure C.5: Genes detected: SALINITY dataset. The symbol ”1” represents the genes
detected by the inverse-Gaussian model. Symbols ”1” and ”2” represent the genes de-
tected by the GAM model (including those detected by the inverse-Gaussian model).
Symbols ”1”, ”2” and ”3” represent the genes detected by the multiplicative gamma
model
178



































































































































































































































































Figure C.6: Genes detected: SALINITY dataset. The symbol ”1” represents the genes
detected by the inverse-Gaussian model. Symbols ”1” and ”2” represent the genes de-
tected by the GAM model (including those detected by the inverse-Gaussian model).




DROUGHT dataset: Plots of the
gene detected
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Figure D.1: Genes detected: DROUGHT dataset. The symbol ”1” represents the genes
detected by the inverse-Gaussian model. Symbols ”1” and ”2” represent the genes de-
tected by the GAM model (including those detected by the inverse-Gaussian model).
Symbols ”1”, ”2” and ”3” represent the genes detected by the multiplicative gamma
model
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Figure D.2: Genes detected: DROUGHT dataset. The symbol ”1” represents the genes
detected by the inverse-Gaussian model. Symbols ”1” and ”2” represent the genes de-
tected by the GAM model (including those detected by the inverse-Gaussian model).
Symbols ”1”, ”2” and ”3” represent the genes detected by the multiplicative gamma
model
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Figure D.3: Genes detected: DROUGHT dataset. The symbol ”1” represents the genes
detected by the inverse-Gaussian model. Symbols ”1” and ”2” represent the genes de-
tected by the GAM model (including those detected by the inverse-Gaussian model).
Symbols ”1”, ”2” and ”3” represent the genes detected by the multiplicative gamma
model
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Figure D.4: Genes detected: DROUGHT dataset. The symbol ”1” represents the genes
detected by the inverse-Gaussian model. Symbols ”1” and ”2” represent the genes de-
tected by the GAM model (including those detected by the inverse-Gaussian model).
Symbols ”1”, ”2” and ”3” represent the genes detected by the multiplicative gamma
model
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Figure D.5: Genes detected: DROUGHT dataset. The symbol ”1” represents the genes
detected by the inverse-Gaussian model. Symbols ”1” and ”2” represent the genes de-
tected by the GAM model (including those detected by the inverse-Gaussian model).
Symbols ”1”, ”2” and ”3” represent the genes detected by the multiplicative gamma
model
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Figure D.6: Genes detected: DROUGHT dataset. The symbol ”1” represents the genes
detected by the inverse-Gaussian model. Symbols ”1” and ”2” represent the genes de-
tected by the GAM model (including those detected by the inverse-Gaussian model).




Banerjee, A. & Bhattacharyya, G. 1979, ‘Bayesian results for the inverse Gaussian distribution
with an application’, Technometrics 21, 247–251.
Benjamini, Y. & Hochberg, Y. 1995, ‘Controlling the False Discovery Rate : a practical
and powerful approach to multiple testing’, Journal of the Royal Statistical Society
57, 289–300.
Berger, J. 1980, Statistical decision theory : Foundations, concepts and methods, Springer-
Verlag New York Inc.
Betro, B. & Rotondi, R. 1991, ‘On Bayesian inference for the inverse Gaussian distribution’,
Statistics and Probability Letters 11, 219–224.
Bressan, R., Zhang, C., Zhang, H., Hasegawa, P., Bohnert, H. & Zhu, J. 2002, ‘Learning
from the Arabidopsis experience. The nect gene research paradigm’, Plant Physiology
127, 1354–1360.
Bussemaker, H., Li, H. & Siggia, E. 2001, ‘Regulatory element detection using correlation
with expression’, Nature Genetics 27, 167–171.
Chhikara, R. 1986, Inverse Gaussian distribution: theory, methodology and applications, New
York: M. Dekker.
Conlon, E., Liu, X., Lieb, J. & Liu, J. 2003, ‘Integrating regulatory motif discovery and
genome-wide expression analysis’, Proc’ Nat’l Acad. Sci. USA 100(6), 3339–3344.
Cox, D. & Hinkley, D. 1974, Theoretical Statistics, Chapman and Hall, London.
188
Cui, H., Kerr, K. & Churchill, G. 2002, Data transformation for cDNA microarray data.
Submitted.
Cui, X. 2004, Statistical tests for differential expression in cDNA microarray. Submitted to
Genome Biology.
Dudley, R. & Haughton, D. 2002, ‘Asymptotic normality with small relative errors of posterior
probabilities of half-spaces’, The Annals of Statistics 30(5), 1311–1344.
Dudoit, S., Fridlyand, J. & Speed, T. 2002, ‘Comparison of discrimination methods for the
classification of tumors using gene expression data’, Journal of the American Statis-
tical Association 97(457), 77–87.
Dudoit, S., Shaffer, J. & Boldrick, J. 2003, ‘Multiple hypothesis testing in microarray experi-
ments’, Statistical Sciences 18(1), 71–103.
Dudoit, S., van der Laan, M. & Pollard, K. 2004, ‘Multiple testing. Part I. Single-step proce-
dures for control of general Type I error rates’, Statistical Applications in Genetics
and Molecular Biology 3(1). Article 13.
Efron, B. 2003, ‘Robbins, Empirical Bayes and microarrays’, Annals of Statistics 31(2), 366–
378.
Efron, B., Storey, J. D. & Tibshirani, R. 2001, Microarrays, Empirical Bayes methods and
False Discovery Rate, Technical Report 218, Department of Statistics, Stanford uni-
versity.
Efron, B. & Tibshirani, R. 1986, An introduction to the bootstrap, CRC Press.
189
Gelman, A. & Tuerlinckx, F. 2000, ‘Type S error rates for classical and Bayesian single and
multiple comparison procedures’, Computational Statistics 15, 373–390.
Genovese, C. & Wasserman, L. 2002a, A large sample approach to False Discovery Rates,
Technical report, Department of Statistics, Carnegie Mellon University, Pittsburgh.
Genovese, C. & Wasserman, L. 2002b, ‘Operating characteristics and extensions of the FDR
procedure’, Journal of the Royal Statistical Society 64, 499–518.
Haab, B., Dunham, M. & Brown, P. 2001, ‘Protein microarrays for highly parallel detection
and quantitation of specific proteins and antibodies in complex solutions’, Genome
Biology 2(2), research 0004.1–0004.13.
Ibrahim, J., Chen, M. & Gray, R. 2002, ‘Bayesian models for gene expression with DNA
microarray data’, Journal of the American Statistical Association 97(457), 88–99.
Ideker, T., Thorsson, V., Siegel, A. & Hood, L. 2000, ‘Testing for differentially-expressed
genes by maximum-likelihood analysis of microarray data’, Journal of Computational
Biology 6, 805–817.
Keles, S., Van der Laan, M., Dudoit, S., Xing, B. & Eisen, M. 2003, Supervised detection of
regulatory motifs in DNA sequences, Technical report, Division of Biostatistics, U.
of California, Berkeley.
Kendziorski, C., Newton, M., Lan, H. & Gould, M. 2002, On parametric empirical Bayes
methods for comparing multiple groups using replicated gene expression profiles,
Technical Report 166, University of Wisconsin, Department of Biostatistics.
190
Kerr, M., Afshari, C., Bennett, L., Bushel, P., Martinez, J., Walker, N. & Churchill, G. 2002,
‘Statistical analysis of a gene expression microarray experiment with replication’,
Statistica Sinica 12, 203–217.
Kerr, M. & Churchill, G. 2001a, ‘Experimental design for gene expression microarrays’, Bio-
statistics 2, 183–202.
Kerr, M., Churchill, G. & Martin, M. 2001b, ‘Analysis of variance for gene expression mi-
croarray data’, Journal of Computational Biology 7, 819–837.
Littel, R., Milliken, G., Stroup, W. & Wolfinger, R. 1996, SAS system for mixed models, SAS
Institute Inc.
Liu, J., Gupta, M., Liu, X., Mayerhofere, L. & Lawrence, C. 2004, Statistical models for
biological sequence motif discovery. To appear in Case Study in Bayesian Statistics,
6.
Liu, J., Neuwald, A. & Lawrence, C. 1995, ‘Bayesian models for multiple local sequence align-
ment and Gibbs sampling strategies’, Journal of the American Statistical Association
90, 1156–1170.
Liu, X., Brutlag, D. & Liu, J. 2002, ‘An algorithm for finding protein-DNA binding sites
with applications to chromatin-immunoprecipitation microarray experiments’, Na-
ture Biotechnology 20, 835–839.
Motoaki, S. & Mari, N. 2002, ‘Monitoring the expression profiles of 7000 Arabidopsis genes
under drought, cold and high salinity stresses using a full-length cDNA microarray’,
The Plant Journal 31(3), 279–292.
191
Muller, P., Parmigiani, G., Robert, C. & Rousseau, J. 2004, ‘Optimal sample size for multiple
testing: the case of gene expression microarrays’, Journal of the American Statistical
Association . To appear.
Newton, M., Kendziorski, C., Richmond, C., Blattner, F. & Tsui, K. 2001, ‘On differential
variability of expression ratios : improving statistical inference about gene expression
changes from microarray data.’, Journal of Computational Biology 8, 37–52.
Newton, M., Noueiry, A., Sarkar, D. & Ahlquist, P. 2003, Detecting differential gene expres-
sion with a semiparametric hierarchical mixture method, Technical Report 1074,
University of Wisconsin-Madison, Department of statistics.
Nguyen, D., Arpart, A., Wang, N. & Carroll, R. 2002, ‘Dna microarray experiments : biological
and technological aspects’, Biometrics 58, 701–717.
Oswald, T., Avery Colin, M. & McCarty, M. M. 1944, ‘Studies on the chemical nature of the
substance inducing transformation of pneumococcal types: Induction pf transforma-
tion by a Desoxyribonucleic Acid fraction isolated from Pneumococcus Type III’,
Journal of Experimental Medicine 79(1), 137–160.
Scholten, D., Miron, A., Merchant, F., Miller, A., Miron, P., Iglehart, J. & Gentleman, R.
2004, ‘Analyzing factorial designed microarray experiments’, Journal of Multivariate
Analysis 90, 19–43.
Shaffer, J. 1999, ‘A semi-Bayesian study of Duncan’s Bayesian multiple comparison procedure’,
Journal of Statistical Planning and Inference 82, 197–213.
Smyth, G. 2004, ‘Linear models and empirical bayes methods for assessing differential expres-
sion in microarray experiments’, Statistical Applications in Genetics and Molecular
192
Biology 3(1), article 3.
Storey, J. 2002, ‘A direct approach to False Discovery Rates’, Journal of the Royal Statistical
Society 64, 479–498.
Storey, J. 2003, ‘The positive False Discovery Rate : a Bayesian interpretation and the q-
value’, Annals in Statistics 31(6), 2013–2035.
Storey, J., Taylor, J. & Siegmund, D. 2004, ‘Strong control, conservative point estimation and
simultaneous conservative consistency of False Discovery Rates: a unified approach’,
Journal of the Royal Statistical Society 66, 187–205.
Van Der Laan, J., Dudoit, S. & Pollard, K. 2004, ‘Multiple testing. Part II. Step-down proce-
dures for control of the Family-Wise error Rate’, Statistical Applications in Genetics
and Molecular Biology 3(1). Article 14.
Weaver, R. 2002, Molecular Biology, second edition edn, McGraw-Hill.
Westfall, P., Johnson, W. & Utts, J. 1997, ‘A Bayesian perspective on the Bonferroni adjust-
ment’, Biometrika 84, 419–427.
Wolfinger, R., Gibson, G., Wolfinger, E., Bennett, L., Hamadeh, H., Bushel, P., Afshari, C. &
Paules, R. 2001, ‘Assessing gene significance from cDNA microarray expression data
via mixed models’, Journal of computational Biology 8, 625–637.
Wu, H., Kerr, K., Cui, X. & Churchill, G. 2003, The analysis of gene expression data: meth-
ods and software, Springer, N.Y., chapter MAANOVA: A Software Package for the
Analysis of Spotted cDNA Microarray Experiments.
193
Yang, Y., Dudoit, S., Luu, P., Lin, D., Peng, V., Ngai, J. & Speed, T. 2002, ‘Normalization for
cDNA microarray data : a robust composite method addressing single and multiple
slide systematic variation’, Nucleic Acids research 30(15).
194
